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 ABBREVIATIONS  
 
ATP                Adenosine triphosphate 
BSA                Bovine serum albumin 
Ca2+                Calcium 
CNS               Central nervous system 
COX               Cyclooxyginase 
Ctr                  Control 
EDTA             Ethylenediaminetetraacetic acid 
EGTA             glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid 
EPO               Erythropoietin 
FACS             Fluorescence-activated cell sorting 
FCS               Fetal calf serum 
FITC               Fluorescein isothyocyanate 
FL                  Fluorescence channel 
FSC               Forward scatter 
g                    gram 
GLUT             Glucose transporter 
GSH              Glutathion 
h                    hour 
Hb                  Hemogblobin 
HCT               Hematocrit 
HEPES          32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 
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IL                    Interleukin 
IONO             Ionomycin 
JAK               Janus kinase 
K+                  Potassium 
KCC              K+/Cl- cotransporter 
mM                Milimolar 
Na+                Sodium 
NF                 Nuclear factor 
NHE              Na+/H+ exchanger 
NO                Nitric oxide 
PAF               Platelate activating factor 
PBS              Phosphate-buffered saline 
PGE2            Prostaglandin E2 
PGN              Peptidoglycan 
PLA               Phospholipase A 
PPAR            Peroxisome proliferators activated receptor 
PS                 Phosphatidylserine 
SDS              Sodium dodecyl sulfate 
SEM              Standard error of the mean 
SM                Sphingomyelin 
SSC              Side scatter 
t-BHP            Tert-butylhydroperoxid 
(VI)              Hexavalent  
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Chapter 1 
 
1. INTRODUCTION 
1.1. Premise 
 Blood is considered a circulating tissue comprising cells (red blood cells, 
white blood cells, platelets) with fluid matrix plasma. Blood is also classified as a 
connective tissue, depending on its origin root in the bones as well as to its role. 
In a healthy body various functions are performed by blood, some of them is to 
deliver oxygen and nutrients to the body’s cells, also to spread warmth to those 
tissues that need it the most, filter injurious waste products such as carbon 
dioxide out of the body, defend against diseases, also  maintain the optimum 
pH of the intracellular fluid in order to work the cells’ enzyme systems efficiently. 
 The formation of red blood cells (RBC) in the myeloid tissue is called      
erythropoiesis and is stimulated by the hormone-erythropoietin (EPO) 
synthesized by the kidneys. The hormone erythropoietin stimulates erythrocyte 
formations from undifferentiated pluripotent stem cells which continuously divide 
and give rise to various blood cells1. They lose nuclei upon maturation, and take 
on a biconcave, dimpled shape with an average diameter of  6-8 µm, and a 
thickness of 1.5-1.8 µm. Humans have roughly about 4-6 million erythrocytes 
per cubic millimetre of blood. 
 Due to the absence of nucleus and mitochondria in Erythrocytes, the total 
intracellular space is available for O2 transport, bearing in mind that these cells 
do not use any of the oxygen they carry2. 
 RBC's live about 120 days and do not self-repair3. At the end of their life, 
they are retained, e.g. - by the spleen, where they undergo physiological 
phagocytosis. 
  
 
1. INTRODUCTION 10 
1.2. Membrane Composition of Red Blood Cells 
 Erythrocytes have a coating around them is so- called the cell membrane. 
This membrane includes the entire cell material within it and plays many 
principal roles. 
 In order to meet with the demands of function, the red cell membrane 
should have specific properties, cellular flexibility, cell recognition, immune 
response and adhesion properties. The composition of the cell membrane 
determines its properties. The membrane is freely permeable to water, oxygen, 
carbon dioxide, glucose, urea, and certain other substances, but it is 
impermeable to haemoglobin.  
 The membrane of erythrocytes is usually composed of a lipid bilayer, 
integral membrane proteins and a membrane skeleton. Phospholipids and 
cholesterol form the lipid bilayer, where phospholipids are asymmetrically 
dispersed in the bilayer4. The outer monolayer contains mainly 
phophatidylcholine and sphingomyelin, where the inner one include 
phosphatidylethanolamine, phosphatidylserine (PS) and to a lesser extent, 
phosphoinositide constituents. Dependent or independent of energy, various 
phospholipids transport proteins such as scramblases, flippases and floppases 
have proven involvement in the phospholipids movement 5. 
 A large number of membrane proteins come from diversified blood group 
antigens. The most important membrane proteins could be mentioned as: band 
3, Glut 1, Kidd antigen protein, aquaporin 1, Na+-K+-ATPase, Ca2+-ATPase, 
Na+/K+/2Cl−co-transporter, Na+-Cl- cotransporter, Na+-K+ cotransporter, K+/Cl− 
co-transport, and Gardos channel. ICAM-4 and laminin binding protein function 
as adhesion proteins. 
 The red cell membrane skeleton is a group of protein complexes 
constructed by structural proteins encompassing α and β spectrin, ankyrin, 
protein 4.1, actin, adducin, dermatin, tropomyosin and tropomodulin. Key 
regulators of membrane mechanical stability are the spectrin dimer-dimer 
interaction and the spectrin actin - protein 4.1R junctional complex. Moreover, 
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they play a crucial role in withstanding shear stresses in the circulation6, 7, 8. 
 
1.3. Membrane Ion transport in Erythrocyte 
 The unceasing traffic of ions in erythrocyte is undergoing to various 
regulating transporters such as : (1) the Gardos channel, (2) Ca2+-ATPase, (3) 
Na+-K+-ATPase, (4) K+/Cl− co-transport, (5) Na+/K+/2Cl− co-transporter, (6) Band 
3 anion exchanger, (7) glucose transporter 9 (figure. 1). 
 
 
 
 
 
  
 
 
 
 
 
Figure 1: Ionic transport pathways in the erythrocyte membrane (Maher and 
Kuchel 2003). 
 
 
 The plasma membrane Ca2+ ATPase (PMCA) is a transporting protein 
embedded in the membrane of erythrocytes, which serves as vital regulator of 
Ca2+ amount within cells by removing the cytosolic calcium (Ca2+). The entry of 
the ion into cells is driven by a very large transmembrane electrochemical 
gradient of Ca2+, therefore it is very important for cells to maintain low 
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concentrations of Ca2+  for proper  cell signalling, thus cells use ATP molecules 
as a power supply for Ca2+- pump, where they are introduced as a power after 
suffering hydrolysis. Ultimately, calcium ions are ejected outside the cell. 
 In principle, the blocking of Ca2+ ATPase protein by one of ATPases 
blockers such as vanadate (VO43–) 10 will keep cytosolic (Ca2+) at high levels, 
which in turn will induce the apoptosis of erythrocytes11. 
 The Na+/K+-ATPase with energy-dependent system is an intrinsic 
membrane protein (Figure 2). It is responsible for pumping Na+ and K+ against 
their membrane gradient12. It mediates the transport of three  Na+ ions out of the 
cell and two K+ ions into the cell per ATP molecule, where it catalyzes the 
hydrolysis of ATP to active transport of Na+/K+ across the cell 13. 
 
 
 
Figure 2: Na+/K+-ATPase pumb ( Molecular Biology of the Cell, 4th edition. 
Alberts. B et al. New York, USA). 
 
 
  A Ca2+-sensitive K+ channel (Gardos channel, hIK1, or hSK4) is the major 
route, by which the cellular loss of KCl takes place, this results in an obliged 
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cellular water loss and consequently cell shrinkage 3. Approximately 100-200 
Gardos channels are found in the erythrocyte membrane14, 15, 16. Gardos 
channel activation is stimulated by high relative levels of intracellular 
Ca2+ concentrations, which in turn increases the mean K+ flux through the 
plasma membrane,17, 18, 19. Dehydrated erythrocytes is the hallmark of sickle cell 
disease, it is followed by the loss of K+, Cl- and water from the cell9. 
 
 
 
Figure 3: schematic representation of the monomeric subunit of the Gárdos 
channel in a cell membrane as predicted by Vandorpe et al. (1998). 
 
 
 Tram34 (1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole), clotrimazole,   
Charybdotoxin, are common pharmacological inhibitors of the Gardos channel 9, 
20. 
 
 The KCl cotransporter  is a protein involved in the active 
transport of  potassium and chloride traffic across the cell membrane. It is 
abundant in erythroid precursors21, 22 but  also have a reduced activity during  
the erythrocytes maturation 3. Independently of the membrane potential, the KCl 
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cotransporter mediates mainly a strictly coupled electroneutral transport of K+ 
and Cl- 23.  
 
1.4. Apoptosis 
 Multicellular organisms do not become infinitely large according to one 
fact, that the proliferation of cells is balanced by cell death. Cells die through 
two different ways, one is accidental, often referred to as necrosis, it is a result 
of mechanical trauma or exposure to some kind of toxic agent. In injured cells, 
the concentrations of ATP can decrease abruptly, where Na+/K+ ATPase can no 
longer operate, therefore, this stop results in ionic imbalances, cell swelling and 
subsequent release of cytoslic contents to the exterior.  
 The other type of death is deliberate, where cells die by suicide 
mechanism known as apoptosis, they shrink bundling their contents into small 
membrane-bound packets named blebs. The nuclear DNA is broken into small 
fragments, each one is enclosed in a small part of the nuclear envelope 24. The 
modified plasma membrane of the dying cell signal to macrophages, 
parenchymal cells, or neoplastic cells, which in turn engulf the cell debris and 
degrade them within phagolysosomes, so that inhibition of the inflammation is 
achieved by secreting special cytokines. Apoptosis is used basically as a 
defence mechanism in response to immune reactions or to damaged cells by 
disease or detrimental agents 25. Inappropriate apoptosis either too little or too 
much is a hall mark in many human pathological conditions including 
neurodegenerative diseases, ischemic damage, autoimmune disorders, 
cardiovascular diseases, acquired immunodeficiency syndrome (AIDS) and 
many types of cancer 25. 
 A part of the cellular constitution in addition to diverse factors outside the 
cellular environment can play a substantial role in apoptosis induction26. Two 
main pathways have been described in apoptosis, the extrinsic (death receptor-
mediated) and the intrinsic (mitochondria-dependent) pathways. The intrinsic 
pathway launches within the cell triggered by variety of stimuli such as DNA 
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damage, stress, or the deprivation of a growth factor. It is depicted as 
mitochondria-dependent pathway where the mitochondria play a central role in 
the apoptotic procedure.  
 Mitochondria-dependent pathway activating brings on permeabilization of 
the outer membrane of the mitochondria, cytochrome C realeas and  caspases 
9 activation, which in turn stimulates the downstream caspase 3. Caspase 3 
takes it upon himself to break down the main cell structures, to this end, the 
actual degrading enzymes are regulated indirectly by mitochondrial permeability 
(figure 4). 
 The extrinsic pathway is considered  the more dynamic, where the 
extracellular environment events control the spark of its beginning and thus the 
cell death. It is expressed as constant interaction between the cell and stimuli 
derived from the external environment, where viruses, radiation, and drugs may 
all act as stimuli. Cells are known to possess death receptors on thier surface, 
this death domain plays a critical role in transmitting the death signal from the 
cell surface to the intracellular signalling pathways. The binding of certain 
ligands to these death receptors on the cell surface such as FAS will be 
followed by the formation of  a death-inducing signalling complex (DISC) which 
activates death caspases 27, 28. In a similar way the TNF inducing ligand (TRAIL) 
operates likewise as the FAS pathway. Processed caspase-8 directly activates 
other members of the downstream caspases such as caspase 3 (figure 4), 
which in turn triggers the execution of cell apoptosis by inducing the cell’s 
chromosomal DNA degradation which leads to fragmentation and subsequently 
the apoptotic demise of the cell 29, 30, 31, 32, 33. 
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Figure 4: Schematic representation of the intrinsic, extrinsic cellular pathways of 
apoptosis (B. Favaloro, 2012). 
 
 
1.5.  Programmed erythrocyte death “Eryptosis” 
 Post a 120-day life span or in response to environmental signals mimic 
mature erythrocytes nucleated cells  in self-destruction, therefore this procedure 
was coined “Eryptosis” to signify the physiological condition of apoptosis or the 
suicidal death of erythrocytes. 
 Eryptosis is characterized by cell shrinkage, cell membrane blebbing and 
membrane phospholipid scrambling with phosphatidylserine exposure at the cell 
surface. Eryptotic cells are removed by macrophages which have special 
receptors, these receptors can identify the exposed phosphatedyl serine on the 
outer leaflet of the apoptotic cell. Subsequently, cells will be engulfed, 
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degraded, and removed from the circulation system and thus prevented from 
undergoing hemolysis. 
 
1.5.1. Eryptosis Inducers 
 Various clinical conditions in addition to a wide range of endogenous 
mediators and xenobiotics have proven their involvement in suicidal erythrocyte 
death. Oxidative stress 34, 35, 36, osmotic shock 37, energy depletion 35, activation 
of the death receptor CD95/Fas 38, Some of the known xenobiotics could be 
presented as eryptosis stimulators such as the following : aluminium 39, 
cadmium 40, lead 41, lithium 42, arsenic 43, selenium 44, silver 45, bismuth 46, tin 
(Nguyen, Foller et al. 2009), zinc 47, amantadine 48, vanadium 49, amiodarone 50, 
amphotericin b 51,   chlorpromazine 52, ciglitazone 53, curcumin 54, cyclosporine 
55, gadolinium 56, hemin 57, hemolysin 58, listeriolysin 59,  methyldopa 60 and 
valinomycin 61. 
 Most xenobiotics set off eryptosis by augmenting cytosolic calcium activity, 
but also on the other side eryptosis could be enhanced by  stimulating ceramide 
formation as reported by methyldopa and menadione 60, 62. We may also 
encounter definite types of triggering eryptosis like phytic acid that decreases 
only the cellular ATP content 63. Thymoquinone induced suicidal erythrocyte 
death employing the induction of protein kinase C pathway without being 
depend on the appreciable stimulation of ceramide or intracellular calcium 
activity64. 
  The hindering of PGE2 formation and antioxidant activity as a mechanism 
proved its ability and efficacy to inhibit Ca2+ permeable cation channels partially 
or completely and thus attenuates suicidal erythrocyte death. However, 
Eryptosis is inhibited by nitric oxide, catecholamines and a variety of further 
small molecules 65, 66. Erythropoietin plays a dual role, on one hand 
erythropoietin partially inhibits the Ca+2 permeable cation channels which 
counteract eryptosis. On the other hand, it contrarily may foster the formation of 
erythrocytes by prolonging the life span of circulating erythrocytes via inhibition 
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of the apoptosis of erythrocyte progenitor cells and slowing the clearance of 
mature erythrocytes. This effect explains the tow mechanisms which 
erythobiotin depends on 67. Eryptosis is also inhibited by resveratrol 68, 
flufenamic acid 69, caffeine 70, zidovudine 71, vitamin C 72, thymol 73. Adenosine 
is also an inhibitor of eryptosis 74. Staurosporine can play as Pharmacological 
inhibition of eryptosis by inhibiting protein kinase C75. Blunting suicidal 
erythrocyte can be achieved by Urea, which abrogates ceramide formation 76. 
 
1.5.2. Ion channels in eryptosis 
  The altered activity of ion channels is the turning point of apoptosis 
machinery. Different channels in erythrocytes like Cl- channels, Ca2+-permeable 
cation channels and Ca2+ -sensitive K+ channels etc regulate the death 
machinery. The channels modify intracellular ion composition and contribute to 
apoptotic cell shrinkage. Cl- channels is responsible for cell shrinkage and 
cytosolic acidification by permitting the exit of HCO3-. K+ exit through Gardus 
channel contributes to cell shrinkage and minimize intracellular K+ 
concentration, which in turn fosters apoptotic cell death. Cell membrane 
potential is determined by K+ channel activity, which has the upper hand at Ca2+ 
entry through Ca2+ channels. Ca2+ may enter intercellular environment through 
nonselective cation channels and activates several enzymes that carry out 
apoptosis in response to the cytosolic Ca2+ signal augmentation. Suicidal cell 
death could be promoted or impaired by Specific ion channel blockers. 
 
1.5.3. Ca2+ permeable cation channels 
 The elevation of cytosolic Ca2+ activity in epoptosis may result from 
activation of monovalent and divalent cation-permeable channels known as 
nonselective cation channels that mediate Ca2+ entry77. The molecular identity 
of the cation channels is so far not completely understood, but supposedly 
involves the transient receptor potential channl TRPC6 77.  A wide variety of 
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challenges can activate cation channels comprising osmotic shock, oxidative 
stress, and Cl– removal 78, they affect at least partially by way of stimulation of 
cyclooxygenase with  the generation of prostaglandin E2, which in turn activate 
the cation channel66. This augment of cytosolic Ca2+ promotes Gardos channels 
activation which mediate K+ loss together with Cl- via parallel anion pathways 
resulting in osmotic water loss and subsequently cell shrinkage79. 
Simultaneously, high intracellular Ca2+ level activates a membrane scramblase 
that increases the abundance of phosphatidylserine in the outer leaflet of the 
erythrocyte membrane 79. 
 
1.5.4. Cl- channels 
 In general, Cl− channels play a crucial role in controlling the ionic 
composition of the cytoplasm and the volume of cells. It is one of the most 
important players in the eryptosis events, where its activation leads to 
depolarize the cell membrane by the exit of the Cl- ion, this efflux is usually 
accompanied with K+ exit. The loss of the somatically active KCl is paralleled by 
the loss of osmotically obliged water and subsequent cell shrinkage, one of the 
decisive Manifestations of eryptosis 80. 
 HCO3 – exit is also considered as Cl- channels activation outcome 
resulting in cytosolic acidification. The inhibition of the Na+/H+ -exchanger during 
apoptosis may have the upper hand in the acidification process. This inhibition 
is due to at least partially caspase-dependent degradation of the carrier protein 
NHE1 81, 82, 83, 84. 
 
1.5.5. Oxidative stress and eryptosis 
 Oxidative stress is one of the most frequent triggers of eryptosis 36. 
Defects of  the antioxidative defence trigger eryptosis in part by stimulating Ca2+ 
entry via activation of the Ca2+ permeable cation channels 85, 86, 87, Oxidative 
stress also go further to activate erythrocyte Cl- channels, which play a basic 
  
 
1. INTRODUCTION 20 
role in erythrocyte shrinkage so that  it participates in eryptosis triggering 88, 89, 
90. The stimulation of eryptosis by oxidative stress is proven to be paralleled by 
aspartyl and cysteinyl proteases activation91. Caspases have been shown to be 
expressed in erythrocytes92, 93  and activated in response to oxidative stress 34, 
91, they play an interesting role via cleaving the anion exchanger band 3 94 and 
stimulating phosphatidylserine exposure 93. However, Caspases activation is 
not an irreplaceable requirement for ionomycin or hyperosmotic shock induced 
eryptosis 76, 95, 96. 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 5: Scheme shows shear stress-induced Ca2+-dependent mechanisms in 
RBCs (Barvitenko, Adragna et al. 2005). 
 
1.5.6. Cycloxygenase and Prostaglandin E2 pathway 
 Hyperosmotic shock and Cl- removal trigger the release of 
prostaglandin E2 (PGE2)66, 78.  Where cation channels are activated as 
a result of PGE2 formation66, this in turn will lead to increase of the 
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cytosolic Ca2+ concentration66, 97, and thus stimulates 
phosphatidylserine exposure at the erythrocyte surface66, subsequently, 
cell membrane blebbing. Cyclooxygenase inhibitors such as 
diclophenac and acetylsalicylic acid in addition to phospholipase-A2 
inhibitors such as quinacrine and palmitoyltrifluoromethyl-ketone could 
abolish pharmacologically the activation of the cation channels by Cl- 
removal 66, PGE2 proved its role via activating the Ca2+ dependent 
cysteine endopeptidase calpain, but apparently was not required for 
stimulation of phosphatidylserine exposure 66. 
 
 
 
Figure 6: Synopsis of the eryptosis mechanism  (Lang, Lang et al. 2006).COX, 
cyclooxygenase; PAF, platelet activating factor; PGE2, prostaglandin E2; PLA2, 
phospholipase A2; GSH, glutathione and NSC, nonselective cation channel. 
 
1.5.7. Ceramide is formed by a sphingomyelinase following 
several stressors 
 The absence of calcium could not fully block the effect of osmotic 
shock on phosphatidylserine exposure98. this drew attention to other 
involved mechanisms and excluded the entirely role of nonselective 
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cation channel. Osmotic shock resulted in the occurrence of ceramide 
at the erythrocyte surface98, C6-ceramide revealed in further 
experiments its ability to trigger eryptosis upon treatment with bacterial 
sphingomyelinase98. However, induced eryptosis by osmotic shock can 
be inhibited by the sphingomyelinase inhibitor 3,4-
dichloroisocoumarin11. Moreover, the nominal absence of Ca2+ in 
hypertonic medium blunted the induction of eryptosis but not total 
abolished98. Accordingly, the presence of C6 ceramide accelerated 
eryptosis post osmotic shock exposure. Due to cell shrinkage, the 
phospholipid mediator platelet activating factor (PAF) is released, which 
in turn stimulates the breakdown of sphingomyelin and the formation of 
ceramide in erythrocytes66, thus PAF participates in the stimulation of 
the sphingomyelinase activation and subsequent “eryptosis”11. PAF 
further triggers cell shrinkage and phosphatidylserine exposure of 
erythrocytes99. The stimulation of phosphatidylserine exposure is 
blunted by the genetic knockout of PAF receptors (PAF receptor 
knockout mice), and by the PAF receptor antagonist ABT49166. 
 
1.5.8. The physiological importance of eryptosis and its role in 
diseases 
 Eryptosis is an extra magnificent process, by which the circulating blood 
gets rid of defective erythrocytes avoiding the negative side injuries of 
hemolysis. Phagocytes are equipped with specific receptors sensing 
phosphatidylserine, which are exposed by apoptotic erythrocytes as a detected 
signal by phagocytes’s navigator. Engulfed erythrocytes are degraded and thus 
cleared from blood stream 100. Eryptosis has shown disclosed in various clinical 
dysfunctions and normal physiological processes its ability to limit erythrocyte 
survival. The cytosolic calcium activity remarkably increased at ageing 
erythrocytes 101. The Life span of erythrocytes was significantly shortened in 
many haematological disorders, in sickle cell disease and glucose-6-phosphate 
dehydrogenase deficiency erythrocytes were more sensitive to stressors 
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impacts as osmotic shock, energy depletion and oxidative stress and jogged to 
eryptosis faster than healthier erythrocytes35. Energy depletion attenuates the 
Na+/K+ –ATPase function, cell swelling is resulted from the leakiness of the cell 
membrane which enhances the accumulation of Na+, Cl- and osmotically 
obliged water 102. In general Na+ entry is followed by the cellular loss of K+ 
which brings on decreasing the equilibrium potential of K+, gradual 
depolarization and entry of Cl-. Erythocytes rupture could be the result of 
swelling releasing the intracellular haemoglobin into the blood circulation. 
Haemoglobin filtration procedure take place in the glomeruli, thus the 
precipitation of free haemoglobin in renal tubules could cause acute renal 
failure11. To this result, eryptosis pop up as protective technique works against 
excessive hemolysis 11, 103.  
 Eryptosis can play  a crucial role in limiting the aggressive invasion of 
malaria Plasmodium falciparum by influencing the course of  the pathogen 104. 
The parasite induces novel permeability pathways (NPP) in the intact cell 
membrane facilitating the exchange of nutrients and disposal of waste products 
105. The oxidation of the cell membrane is the way used by parasites to activate 
host cell channels and these channels constitute the NPP. Cation channels 
which increase cytosolic Ca2+ and Na+ are playing here dual function, it is 
indispensable for parasite survival, in addition to its activation which leads to 
eryptosis . 
 
1.6. Environmental contaminants 
 Environmental contaminants are substances that have the potency to 
harm people by loading accidentally or deliberately into environment, wildlife 
and plants. A Hazardous substance, as defined in s. 292.01, Wis. Stats., means 
“any substance or combination of substances, including any waste of a solid, 
semisolid, liquid or gaseous form which may cause or significantly contribute to 
an increase in the mortality or an increase in serious irreversible or 
incapacitating reversible illness, or which may pose a substantial present or 
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potential hazard to human health or the environment because of its quality, 
concentration or physical, chemical or infectious characteristics. This term 
includes, but is not limited to, substances that are toxic, corrosive, flammable, 
irritants, strong sensitizers or explosives”106. People's exposure to chemicals or 
toxins in the environment requested a special expression known as 
biomonitoring, it is the direct measurement that indicates the amount of a 
chemical that actually gets into people from all environmental sources, 
containing substances measuring, or detecting the products in human 
specimens such as blood and urine after their breaking down. With such bio 
monitoring measurements, the most health-relevant assessment of exposure 
will be available. 
 
1.6.1. Hexavalent Chromium 
 Potassium dichromate is an orange-red colour powder with the molecular 
weight of 294 g/mol, 
 
   
 
 
Figure 7: Potassium dichromate, the chemical structure and its crystal normal 
form (wikimedia). 
 
it was awarded a wide spectrum of names as potassium bichromate, dichromic 
acid, dipotassium salt, chromic acid, bichromate of potash, dipotassium salt, 
and dipotassium dichromate. It has a chemical formula: K2Cr2O7. 
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 Potassium dichromate could exist as result of the chemical reaction of 
chromium trioxide and potassium hydroxide in a reactor creating mother liquor. 
The reaction is as follows: 
 
2 CrO3 + 2 KOH = K2Cr2O7  + H2O 
 The widespread industrial application of this heavy metal resulted in the 
global occurrence of soluble hexavalent (VI) chromium,  which pushed it to 
enter the ranking as a critical environmental pollutant 107, 108. Chromium as a 
pollutant is found  in such components of wood preservatives, pigments, 
anticorrosive primers, metal plating, fossil fuel, etc109, and in nature could be 
encountered in two main species, the relative innocuous form trivalent Cr(III), 
and the hexavalent form Cr(VI) rated more toxic species 107, 108. Aqueous Cr(VI)  
could  reach serious levels in surface and ground water, where the contaminant 
Cr(III)  undergoes natural processing through oxidation converting it into the 
dissolved form 110. Releasing chromium from orthodontic appliances can do 
damage the DNA in oral mucosa cells of children111. Chromium may further be 
released from metal on stainless steel implants 112, 113, 114. Elevated 
concentration of hexavalent chromium pollution leads to health hazards of 
mining in India115. Oxidative stress, inflammation, cell proliferation, malignant 
transformation, growth arrest, cytotoxicity, and apoptosis are triggered by 
Chromium (VI) which is absorbed in the intestines 116, 117, 118, 119, 120. DNA 
damage including base modification, mitochondrial damage as well as single-
strand breaks, double-strand breaks, Cr–DNA adducts, DNA–Cr–DNA adducts, 
protein–Cr–DNA adducts, and mutagenesis are mostly the implicated 
mechanisms in chromium (VI) toxicity 116, 121, 122. 
 
1.6.2. Rotenone 
Rotenone, an odorless chemical of botanical origin,  is obtained from 
extracts of Derris root and Lonchocarpus plants 123.  
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Figure 8: Structural formula of Rotenone and its crystal normal form ( Alibaba 
Hebei Chinally International Trade Co., Ltd.). 
 
It has been utilized extensively for a long time as a broad-
spectrum insecticide and pesticide, In California, 200 kg of rotenone per year is 
used as insecticide for organically grown lettuce and tomatoes124. It is a 
flavonoid, naturally formed in stems of several plants and in various seeds as 
well, such as the jicama vine plant 125, 126, 127. Rotenone is considered an 
environmental factor and has been implicated in neuronal cell death of 
Parkinson’s disease (PD)125, 128. It is a lipophilic compound that can easily 
access cytoplasm and mitochondria by crossing cell membranes. Due to 
Rotenone`s involvement in the production of many features of PD in rats, its 
application in PD research has enlarged exponentially over the last few years 
largely,  This is including development of α-synuclein-positive cytoplasmic 
inclusions similar to LBs in human PD in the remaining nigral neurons129. 
Neurons themselves showed also toxic sensitivity to rotenone130, 131, 132, 133. 
Animals treatment with Rotenone reproduce a neurochemical and 
neuropathological feature of Parkinson's disease 127, 134, 135, 136. Rotenone has a 
capacity to induce neoplastic, paraneoplastic and preneoplastic lesions so that 
it is strongly suggested to be carcinogenic 126. However, It is published that, 
effective modulators could penetrate multidrug resistance (MDR) proteins that 
belong to the ATP-binding cassette superfamily in tumor cells such as 
rotenone137. The mechanism which rotenone depends on is at least in part 
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effective by interference with mitochondrial function in turn induced the suicidal 
cell death 138, 139, 140, 141, 142, 143. 
 
1.7.  Natural products 
 Compounds, organic molecules, naturally occurring as end products of 
secondary metabolism. They are often isolated from animals, plants, or 
microbes, and are considered unique compounds for particular organisms or 
classes of organisms; Natural products are the cornerstone of modern 
therapeutics. They fulfil an important role in the development of therapeutic 
agents. Many of the natural products of medicinal value offer us new sources of 
drugs which have been used effectively for centuries in traditional medicine.  
 Plants are sources of hallucinogens, poisons, and addictive drugs. Wide 
range of people has preference to use natural products from plants for 
preventive medicine, but potential harmful effects of such compounds should 
put in account. 
 
1.7.1.  Apigenin 
 Flavonoids have been considered recently as being potential 
chemotherapeutic agents depending on their biological activities, which include 
involvement in cell cycle arrest in addition to stimulation of Apoptosis144.  
 
  
Figure 9: structural formula of Apigenin and its powder form (skinactives.com). 
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 Apigenin is a yellow crystalline solid  natural product, classified as a 
flavone subclass of Flavonoids,  and can be encountered in vegetables and 
fruits and further plant materials 145, 146. It is believed to have a number of 
biological function including anti-inflammatory, anticancer, and free-radical 
scavenging147, 148, 149. Malignant cancer cell line researches indicated to the 
inhibiting role of Apigenine in cancer cell activity by enhancing cell cycle arrest 
and apoptosis 150, 151. Apigenin exhibits antiproliferative activity in human breast 
cancer cells152. This flavones also triggers autophagia which reflects its 
chemopreventive properties, concurrently it induces resistance against 
chemotherapy153. Moreover, Apigenin reportedly showed nonmutagenic and low 
toxicity compared to related flavonoides154.  This flavon has shown ability to 
counteract inflammation, oxidative stress and  the development of cancer 146, 
155. The protective effect of apigenin against tumor growth is at least partially 
due to  the induction of apoptosis 156. On the other hand, apigenin may protect 
against apoptosis 157. 
 The apoptosis stimulating effect is at least partially due to  the influence of 
apigenin on mitochondria 158 and on gene expression 159. Apigenin is partially 
effective through  the targeting of the JAK/STAT pathway 153. 
 
1.7.2. Honokiol 
 The polyphenol honokiol [(3,5-di-(2-propenyl)-1,1-biphenyl-2,2-diol], 
present in the cones, bark, and leaves of  Magnolia officinalis 160.  
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Figure 10: Honokiol, the chemical structure and its crystal normal form ( Alibaba 
Hebei Chinally International Trade Co., Ltd.). 
 Honokiol is a small molecule that has shown its ability to act as 
antiangiogenic and antitumor in various tumors, including sarcomas, multiple 
myeloma, and chronic lymphocytic leukemia161. Honokiol,  has been used for 
almost three decades as  a muscle relaxant162 also extensive research has 
shown that honokiol inhibits skin tumor promotion 163. The two phenolic groups 
of  the honokiol molecule awarded it antioxidant properties similar to vitamin 
E164  or polyphenols such as flavonoids165, inhibits nitric oxide synthesis and 
tumor necrosis factor (TNF) expression166 167, inhibits invasion 168, down-
regulates antiapoptotic protein Bcl-xL169. Moreover, it has been reported that 
honokiol could inhibit free radical induced lipid peroxidation170 and prevented 
oxidative modification of LDL 171 
 It has previously been shown to counteract inflammation, infection, 
anxiety, depression, stress, angiogenesis, oxidation and malignancy 160, 172, 173, 
174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, The anti-tumor activity of honokiol has 
been attributed to its ability to stimulate apoptosis 160, 185, 186, 187, 188, 189, 190, 191, 192. 
On the other hand, honokiol has been shown to inhibit apoptosis 193, 194, 195. 
Mechanisms mediating effects of honokiol include death receptor pathways 160, 
mitochondria 160, 190, 196, caspases 160, apoptosis-related proteins 172, nuclear 
factor kappa B (NF-κB) 172, signal transducers and activator of transcription 3 
(STAT3) 172, 197, 198, epidermal growth factor receptor (EGFR) 172, 199, mammalian 
target of rapamycin (m-TOR) 172, phospholipase D 196, calpain 200, adhesion 
molecules 189,15-lipoxygenase-1 201. 
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Chapter 2 
 
2. MATERIALS AND METHODS  
2.1.  Modulation of erythrocyte survival by Hexavalent 
Chromium 
2.1.1. Erythrocytes, solutions, and chemicals  
 The blood bank of Tübingen University supplied perpetually the 
Leukocyte-depleted erythrocytes friendly. Before donation, Hepatitis A, B, and C 
, HIV, and syphilis, were tested in the volunteers (age range 18–68 years) 
providing blood. The ethics committee of the University of Tübingen 
(184/2003V) approved this study, the volunteers provided informed consent. At 
a hematocrit 0.4%, pH 7.4, at 37 °C for 48 h, blood samples were incubated in 
vitro in Ringer solution contained (in mM): 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-
hydroxyethylpiperazine- N-2- thanesulfonic acid (HEPES), 5 glucose, 1 CaCl2; 
or in serum as indicated. 1 mM glycol-bis(2-aminoethylether)-N,N,N0,N0-
tetraacetic acid (EGTA) was used to substitute  1 mM CaCl2  in Ca
+2-free Ringer 
solution preparation. This Ca2+ free Ringer solution was used to study the role 
of calcium entry in phsophatidylserine exposure on erythrocytes treated with 
chromium (VI).  CaCl2 was removed in another experiment without addition any 
chelating agent to the solution. Erythrocytes were subjected to potassium 
dichromate (K2Cr2O7; Sigma, Freiburg, Germany), where concentrations 
represent chromium (VI) ions. Ringer solution with 5 mM CaCl2 was used to 
wash the erythrocytes following pre-treatment with both Ringer solutions with / 
without Ca2+ for the indicated time periods, the same solution loaded with FITC-
conjugated Annexin V was used to resuspend the erythrocyte for 20 min which 
is considered too short to trigger eryptosis.  
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2.1.2. FACS analysis of annexin V-binding and forward scatter  
 The protocol Andree, Reutelingsperger 202 was used to perform FACS 
analysis. The pre-treated cells under the respective experimental condition were 
washed with Ringer solution containing 5 mM CaCl2. FITC-conjugated Annexin-
V (Immuno- Tools, Friesoythe, Germany) was used to stain Erythrocytes at a 
1:200 dilution. By flow cytometric analysis (FACS-Calibur from Becton 
Dickinson; Heidelberg, Germany) samples were properly measured after 20 min 
of incubating with light protection at 37C°. Cells volume was estimated by 
forward scatter (FSC) determination, where annexin V fluorescence intensity 
was measured in fluorescence channel FL-1 applying an excitation wavelength 
of 488 nm and an emission wavelength of 530 nm. In the different flow 
cytometric measurements ranged the total events between 10,000 to15,000. 
The standard software CellQuest Pro (BD biosciences) was used to perform the 
data acquisition and analysis. 
 
2.1.3. Measurement of intracellular Ca2+ 
 Pre-incubated suspension of erythrocytes with volume 50 µl was washed 
in Ringer solution and followed later with Fluo-3/AM (Biotium, Hayward, USA) 
loading in Ringer solution containing 5 mM CaCl2 and 2 µM Fluo- 3/AM. The 
cells were reincubated at 37°C for 30 min and washed tow times in Ringer 
solution with 5 mM CaCl2. 200 µl Ringer was used to resuspend Fluo-3/AM-
loaded erythrocytes. Ca2+-dependent fluorescence intensity was measured in 
fluorescence channel FL-1. 
 
2.1.4. Determination of intracellular ATP concentration 
 Intracellular erythrocyte ATP was measured by incubating 90 µl of 
erythrocytes for 48 hours at respective temperature conditions in Ringer 
solution with or without chromium (VI) (final hematocrit 5%). As a 
positive control, glucose-depleted Ringer solution was used instead of 
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Ringer solution by erythrocytes incubation. After Cells lysing in distilled 
water, proteins were precipitated using HClO4 (5%). Following cells 
centrifuging, an aliquot of the supernatant (400 µl) was adjusted to pH 
7.7 by the addition of saturated KHCO3 solution. By employing the 
luciferin- luciferase assay kit (Roche diagnostics) in accordance to the 
manufacturer’s protocol on luminometer (Berthold Biolumat LB9500, ad 
Wildbad, Germany) ATP concentrations of the aliquots were determined 
in mmol/l cytosol of erythrocytes. To avoid ATP degradation, all the 
manipulations in this experiment were performed at 4°C. 
 
2.1.5. Determination of ceramide formation 
 A monoclonal antibody-based assay was used to determine 
Ceramide abundance in erythrocytes. Incubated erythrocytes with and 
without chromium (VI) were stained for 1 hour at 37°C with 1 μg/ml anti- 
ceramide antibody (clone MID 15B4; Alexis, Grünberg, Germany) in 
PBS containing 0.1% bovine serum albumin (BSA) with a dilution of 1:5. 
Following tow times of washing with PBS-BSA, cells were stained with 
polyclonal fluorescein-isothiocyanate (FITC)-conjugated goat anti-
mouse IgG and IgM specific antibody for 30 minutes (Pharmingen, 
Hamburg, Germany) diluted 1:50 in PBS-BSA. Frequent washing with 
PBS-BSA ensures removing unbound secondary antibody. On a FACS-
Calibur in FL-1samples were then analysed by flow cytometric analysis.  
 
2.1.6. Measurement of hemolysis 
To determine the subsequent hemolysis of the treated erythrocytes, the 
samples were undergone to a centrifugation (3 min at 400 x g, room 
temperature), which is followed by supernatants collecting. The 
hemoglobin (Hb) concentration of the supernatant was measured by a 
photometer at 405 nm. lysed erythrocytes in distilled water was 
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specified as 100% hemolysis and determined by reading the 
supernatant absorption.  
 
2.1.7. Confocal microscopy and immunofluorescence 
 4 µl of treated erythrocytes in respective experimental conditions 
was incubated to display their eryptotic condition, the cells were stained 
with FITC-conjugated annexin-V (1:100 dilution; ImmunoTools, 
Friesoythe, Germany) in 200 µl Ringer solution with 5 mM CaCl2. 
Following tow times of erythrocytes washing, cells were resuspended in 
50 µl of Ringer solution with 5 mM CaCl2. Prolong Gold antifade reagent 
(Invitrogen, Darmstadt, Germany) was added to 20 µl sample to mount 
up a glass slide covered with a coverslip. Zeiss LSM 5 EXCITER 
confocal laser scanning microscope (Carl Zeiss MicroImaging, 
Oberkochen, Germany) was used to take images for the eryptotic 
erythrocyte with a water immersion Plan-Neofluar 63/1.3 NA DIC. 
 
2.1.8. Statistics 
 Paired ANOVA with Tukey’s test as post-test were used for 
statistical analysis as indicated in the Figure legends. The arithmetic 
mean ± the standard error of the mean (SEM) has been calculated from 
the averaged values obtained from the different erythrocyte 
preparations. In all graphs, data were expressed as arithmetic means ± 
SEM. n indicates the number of various erythrocyte specimens studied.  
In Both control and experimental conditions the same erythrocyte 
specimens have been used. Specimens are differently susceptible to 
eryptotic effects where different erythrocyte specimens were tested in 
diverse experiments.  
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2.2. Involvement of Rotenone in the erythrocyte cell 
membrane scrambling  
2.2.1. Erythrocytes, solutions and chemicals 
  Experiments were performed at 37°C with isolated erythrocytes 
drawn from healthy volunteers and provided by the blood bank of the 
University of Tübingen. The study is provided with approval from the 
ethics committee of the University of Tübingen (184/2003 V). At a 
hematocrit 0.4%, pH 7.4, at 37 °C for 48 h, blood samples were 
incubated in vitro in Ringer solution contained (in mM): 5 KCl, 1 MgSO4, 
125 NaCl, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 
(HEPES), 5 glucose, 1 CaCl2; pH 7.4 at 37°C for 48 h. Erythrocytes 
were subjected to rotenone (Sigma, Freiburg, Germany) at the donated 
concentrations. To prepare Ca2+-free Ringer solution, 1 mM CaCl2 was 
replaced with 1 mM glycol-bis(2-aminoethylether)- N,N,N_,N_-
tetraacetic acid (EGTA).  
 
2.2.2. FACS analysis of annexin V-binding and forward scatter 
  FACS analysis was performed as described in protocol Andree, 
Reutelingsperger 202. Cells were washed post incubation in Ringer 
solution with 5 mM CaCl2 and followed by Annexin-V-FITC staining 
(1:200 dilution; ImmunoTools, Friesoythe, Germany), where incubated 
at 37°C for 20 min with light protection. In FL-1 the forward scatter 
(FSC) of the cells was determined, and annexin V fluorescence 
intensity was measured using an excitation wavelength of 488 nm and 
an emission wavelength of 530 nm on a FACS Calibur (BD, Heidelberg, 
Germany). To perform annexin V fluorescence analysing a distinct 
marker was placed at the end of the annexin V negative population, 
where the batch analysis was launched acquiring the percentage of 
annexin V positive erythrocytes using the CellQuest Pro software. On 
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the other side, the batch analysing of forward scatter was accomplished 
by recording the geometric mean of the cell population 
 
2.2.3. Measurement of intracellular Ca2+ 
 Pre-incubated suspension of erythrocytes with volume 50 µl was washed 
in Ringer solution and followed later with Fluo-3/AM loading (Biotium, Hayward, 
USA) in Ringer solution containing 5 mM CaCl2 and 2 µM Fluo- 3/AM. For 30 
min at 37°C the cells were incubated and washed afterwards tow times in 
Ringer solution with 5 mM CaCl2. 200 µl Ringer was used to resuspend Fluo-
3/AM-loaded erythrocytes. Ca2+-dependent fluorescence intensity was 
measured in fluorescence channel FL-1. 
 
2.2.4. Determination of ceramide formation 
 A monoclonal antibody-based assay was used to determine 
Ceramide abundance in treated erythrocytes with Rotenon. Incubated 
erythrocytes with and without Rotenon were stained for 1 hour at 37°C 
with 1 μg/ml anti- ceramide antibody (clone MID 15B4; Alexis, 
Grünberg, Germany) in PBS containing 0.1% bovine serum albumin 
(BSA) with a dilution of 1:5. Following tow times of washing with PBS-
BSA, cells were stained with polyclonal fluorescein-isothiocyanate 
(FITC)-conjugated goat anti-mouse IgG and IgM specific antibody for 30 
minutes (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. 
Frequent washing with PBS-BSA ensures removing unbound 
secondary antibody. On a FACS-Calibur in FL-1 samples were then 
analysed by flow cytometric analysis 
 
2.2.5. Measurement of hemolysis 
 To determine the subsequent hemolysis of the treated 
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erythrocytes, the samples were undergone to a centrifugation (3 min at 
400 x g, room temperature), which is followed by supernatants 
collecting. The hemoglobin (Hb) concentration of the supernatant were 
measured by a photometer at 405 nm. lysed erythrocytes in distilled 
water was specified as 100% hemolysis and determined by reading the 
supernatant absorption.  
 
2.2.6. Statistics 
  Paired ANOVA with Tukey’s test as post-test was used for 
statistical analysis as indicated in the Figure legends. The arithmetic 
mean ± the standard error of the mean (SEM) has been calculated from 
the averaged values obtained from the different erythrocyte 
preparations. In all graphs, data were expressed as arithmetic means ± 
SEM. n indicates the number of various erythrocyte specimens studied.  
In Both control and experimental conditions the same erythrocyte 
specimens have been used. Specimens are differently susceptible to 
eryptotic effects where different erythrocyte specimens were tested in 
diverse experiments.  
 
2.3. Participation of Apigenin in eryptosis 
2.3.1. Erythrocytes, Solutions and Chemicals 
 Experiments were performed at 37°C with isolated erythrocytes 
drawn from healthy volunteers and provided by the blood bank of the 
University of Tübingen. The study is provided with approval from the 
ethics committee of the University of Tübingen (184/2003 V). At a 
hematocrit 0.4%, pH 7.4, at 37 °C for 48 h, blood samples were 
incubated in vitro in Ringer solution contained (in mM): 5 KCl, 1 MgSO4, 
125 NaCl, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 
(HEPES), 5 glucose, 1 CaCl2; pH 7.4 at 37°C for 48 h. Erythrocytes 
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were subjected to apigenin (Tocris, Bristol, U.K.) at the donated 
concentrations. To prepare Ca2+-free Ringer solution, 1 mM CaCl2 was 
replaced with 1 mM glycol-bis(2-aminoethylether)- N,N,N_,N_-
tetraacetic acid (EGTA).  
 
2.3.2. FACS Analysis of Annexin V Binding and Forward 
Scatter. 
 FACS analysis was performed as described in protocol Andree, 
Reutelingsperger 202. Cells were washed post incubation in Ringer 
solution with 5 mM CaCl2 and followed by Annexin-V-FITC staining 
(1:200 dilution; ImmunoTools, Friesoythe, Germany) where incubated at 
37°C for 20 min with light protection. In FL-1 the forward scatter (FSC) 
of the cells was determined, and annexin V fluorescence intensity was 
measured using an excitation wavelength of 488 nm and an emission 
wavelength of 530 nm on a FACS Calibur (BD, Heidelberg, Germany). 
 
2.3.3. Measurement of Intracellular Ca2+ 
 Pre-incubated suspension of erythrocytes with volume 50 µl was 
washed in Ringer solution and followed later with Fluo-3/AM loading 
(Biotium, Hayward, USA) in Ringer solution containing 5 mM CaCl2 and 
2 µM Fluo- 3/AM. For 30 min at 37°C the cells were incubated and 
washed afterwards tow times in Ringer solution with 5 mM CaCl2. 200 
µl Ringer was used to resuspend Fluo-3/AM-loaded erythrocytes. Ca2+-
dependent fluorescence intensity was measured in fluorescence 
channel FL-1. 
 
2.3.4. Determination of Intracellular ATP Concentration 
  Intracellular erythrocyte ATP was measured by incubating 90 µl of 
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erythrocytes for 48 hours in the respective temperature conditions in 
Ringer solution with or without chromium (VI) (final hematocrit 5%). As 
a positive control, glucose-depleted Ringer solution was used instead of 
Ringer solution for erythrocytes incubation. After Cells lysing in distilled 
water, proteins were precipitated using HClO4 (5%). Following cells 
centrifuging, an aliquot of the supernatant (400 µl) was adjusted to pH 
7.7 by the addition of saturated KHCO3 solution. By employing the 
luciferin- luciferase assay kit (Roche diagnostics) in accordance to the 
manufacturer’s protocol on luminometer (Berthold Biolumat LB9500, ad 
Wildbad, Germany) ATP concentrations of the aliquots were determined 
in mmol/l cytosol of erythrocytes. To avoid ATP degradation, all the 
manipulations in this experiment were performed at 4°C. 
 
2.3.5. Determination of Ceramide Formation 
  A monoclonal antibody-based assay was used to determine 
Ceramide abundance in treated erythrocytes with Apigenin. Incubated 
erythrocytes with and without Apigenin were stained for 1 hour at 37°C 
with 1 μg/ml anti-ceramide antibody (clone MID 15B4; Alexis, Grünberg, 
Germany) in PBS containing 0.1% bovine serum albumin (BSA) with a 
dilution of 1:5. Following tow times of washing with PBS-BSA, cells 
were stained with polyclonal fluorescein-isothiocyanate (FITC)-
conjugated goat anti-mouse IgG and IgM specific antibody for 30 
minutes (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. 
Frequent washing with PBS-BSA ensures removing unbound 
secondary antibody. On a FACS-Calibur in FL-1samples were then 
analysed by flow cytometric analysis 
 
2.3.6. Measurement of Hemolysis 
 To determine the subsequent hemolysis of the treated 
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erythrocytes, the samples were undergone to a centrifugation (3 min at 
400 x g, room temperature), which is followed by supernatants 
collecting. The hemoglobin (Hb) concentration of the supernatant were 
measured by a photometer at 405 nm. lysed erythrocytes in distilled 
water was specified as 100% hemolysis and determined by reading the 
supernatant absorption.  
 
2.3.7. Statistics 
 Paired ANOVA with Tukey’s test as post-test was used for 
statistical analysis as indicated in the Figure legends. The arithmetic 
mean ± the standard error of the mean (SEM) has been calculated from 
the averaged values obtained from the different erythrocyte 
preparations. In all graphs, data were expressed as arithmetic means ± 
SEM. n indicates the number of various erythrocyte specimens studied.  
In Both control and experimental conditions the same erythrocyte 
specimens have been used. Specimens are differently susceptible to 
eryptotic effects where different erythrocyte specimens were tested in 
diverse experiments.  
 
2.4. Honokiol in the triggering of erythrocyte cell membrane 
scrambling 
2.4.1  Erythrocytes, solutions and chemicals 
  Experiments were performed at 37°C with isolated erythrocytes 
drawn from healthy volunteers and provided by the blood bank of the 
University of Tübingen. The study is provided with approval from the 
ethics committee of the University of Tübingen (184/2003 V). At a 
hematocrit 0.4%, pH 7.4, at 37 °C for 48 h, blood samples were 
incubated in vitro in Ringer solution contained (in mM): 5 KCl, 1 MgSO4, 
125 NaCl, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 
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(HEPES), 5 glucose, 1 CaCl2; pH 7.4 at 37°C for 48 h. Erythrocytes 
were subjected to Honokiol (Enzo, Lörrach, Germany) at the donated 
concentrations. DMSO was used to dissolve Honokiol and the final 
concentration of DMSO in the samples did not exceed 0.15%. To 
prepare Ca2+-free Ringer solution, 1 mM CaCl2 was replaced with 1 mM 
glycol-bis(2-aminoethylether)- N,N,N_,N_-tetraacetic acid (EGTA). 
Substitution of 1 mM EGTA for 1 mM CaCl2 allow the deletion of 
calcium traces derived from extracellular Ca2+ present in the erythrocyte 
concentrates . 
 
 
2.4.2  FACS analysis of annexin-V-binding and forward scatter  
 FACS analysis was performed as described in protocol Andree, 
Reutelingsperger 202. Cells were washed post incubation in Ringer 
solution with 5 mM CaCl2 and followed by Annexin-V-FITC staining 
(1:200 dilution; ImmunoTools, Friesoythe, Germany) where incubated at 
37°C for 20 min with light protection. In FL-1 the forward scatter (FSC) 
of the cells was determined, and annexin V fluorescence intensity was 
measured using an excitation wavelength of 488 nm and an emission 
wavelength of 530 nm on a FACS Calibur (BD, Heidelberg, Germany). 
 In the different measurements by flow cytometry  the total events of 
10,000-15,000 were counted for their analyzing. The standard software 
CellQuest Pro (BD biosciences) was used to perform the data 
acquisition and also analysis. 
 To perform annexin V fluorescence analysing a distinct marker was 
placed at the end of the annexin V negative population, where the batch 
analysis was launched acquiring the percentage of annexin V positive 
erythrocytes using the CellQuest Pro software. On the other side, the 
batch analysing of forward scatter was accomplished by recording the 
geometric mean of the cell population.   
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2.4.3 Determination of erythrocyte diameter 
 Flow Cytometer size calibration Kit (F13838) from Molecular 
Probes was purchased to determine the accurate erythrocyte diameter.  
Short vortex mixing and sonicating pervious to sampling any of the kit 
components were used to suspend the microspheres uniform, where 
the larger microspheres will settle out within minutes. Addition one drop 
of each six standard microspheres to approximately 2 mL of sheath fluid 
or buffered saline was performed to prepaere a mixed suspension of  
six standard microspheres. Nonetheless, a subset of six separated 
suspensions with different diameter is prepared in the given experiment 
depending on the needed size markers. In FL-1well suspended 
microspheres and blood samples were measured. 
 
2.4.4  Measurement of intercellular Ca2+ 
 Pre-incubated suspension of erythrocytes with volume 50 µl was 
washed in Ringer solution and followed later with Fluo-3/AM loading 
(Biotium, Hayward, USA) in Ringer solution containing 5 mM CaCl2 and 
2 µM Fluo- 3/AM. For 30 min at 37°C the cells were incubated and 
washed afterwards tow times in Ringer solution with 5 mM CaCl2. 200 
µl Ringer was used to resuspend Fluo-3/AM-loaded erythrocytes. Ca2+-
dependent fluorescence intensity was measured in fluorescence 
channel FL-1. 
 
2.4.5  Measurement of hemolysis 
 To determine the subsequent hemolysis of the treated 
erythrocytes, the samples were undergone to a centrifugation (3 min at 
400 x g, room temperature), which is followed by supernatants 
collecting. The hemoglobin (Hb) concentration of the supernatant were 
measured by a photometer at 405 nm. lysed erythrocytes in distilled 
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water was specified as 100% hemolysis and determined by reading the 
supernatant absorption.  
 
2.4.6  Confocal microscopy and immunofluorescence 
 4 µl of treated erythrocytes in respective experimental conditions 
was incubated to display their eryptotic condition, the cells were stained 
with FITC-conjugated annexin-V (1:100 dilution; ImmunoTools, 
Friesoythe, Germany) in 200 µl Ringer solution with 5 mM CaCl2. 
Following tow times of erythrocytes washing, cells were resuspended in 
50 µl of Ringer solution with 5 mM CaCl2. Prolong Gold antifade reagent 
(Invitrogen, Darmstadt, Germany) were added to 20 µl sample to mount 
up a glass slide which was covered with a coverslip. Zeiss LSM 5 
EXCITER confocal laser scanning microscope (CarlZeiss MicroImaging, 
Oberkochen, Germany) was used to take images for the eryptotic 
erythrocyte with a water immersion Plan-Neofluar 63/1.3 NA DIC. 
2.4.7  Determination of ceramide formation 
 A monoclonal antibody-based assay was used to determine 
Ceramide abundance in treated erythrocytes with Honokiol. Incubated 
erythrocytes with and without Honokiol were stained for 1 hour at 37°C 
with 1 μg/ml anti-ceramide antibody (clone MID 15B4; Alexis, Grünberg, 
Germany) in PBS containing 0.1% bovine serum albumin (BSA) with a 
dilution of 1:5. Following tow times of washing with PBS-BSA, cells 
were stained with polyclonal fluorescein-isothiocyanate (FITC)-
conjugated goat anti-mouse IgG and IgM specific antibody for 30 
minutes (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. 
Frequent washing with PBS-BSA ensures removing unbound 
secondary antibody. On a FACS-Calibur in FL-1samples were then 
analysed by flow cytometric analysis 
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2.4.8  Statistics 
 Paired ANOVA with Tukey’s test as post-test was used for 
statistical analysis as indicated in the Figure legends. The arithmetic 
mean ± the standard error of the mean (SEM) has been calculated from 
the averaged values obtained from the different erythrocyte 
preparations. In all graphs, data were expressed as arithmetic means ± 
SEM. n indicates the number of various erythrocyte specimens studied.  
In Both control and experimental conditions the same erythrocyte 
specimens have been used. Specimens are differently susceptible to 
eryptotic effects where different erythrocyte specimens were tested in 
diverse experiments. 
  
 
3.  RESULTS 45 
 
 
 
 
 
 
Chapter 3 
 
 
 
 
 
 
Results 
 
 
 
 
 
 
 
  
 
3.  RESULTS 46 
Chapter 3 
 
3.  RESULTS 
 In a non-nucleated cells acquires programmed death special 
interest, where the regulation of cell survival is still relative enigmatic at 
least by talking at non-genomic level. Hence, four different agonists 
were applied on erythrocyte to reveal apoptotic pathways and their 
involved associated signalling. 
 
3.1. Modulation of erythrocyte survival by Hexavalent 
Chromium 
 The present study addressed the effect of Hexavalent Chromium on 
eryptosis. Cytosolic Ca2+ concentration ([Ca2+]i) was determined utilizing 
Fluo3 fluorescence in an attempt to elucidate the mechanisms that 
govern the triggering of erythrocyte shrinkage and cell membrane 
scrambling following Hexavalent Chromium exposure. To this end, 
erythrocytes were loaded with Fluo3-AM and Fluo3 fluorescence 
determined in FACS analysis following incubation in Ringer solution 
without or with Hexavalent Chromium (1-20 µM). As illustrated in Figure 
11. statistically significant increase of Fluo3 fluorescence as a result of 
human erythrocytes treatment with chromium (VI) at a concentration of 
 ≥10 µM, an observations pointing to an increase of cytosolic Ca2+ 
concentration. Ca2+ sensitive K+ channels is activated as a result of an 
increase of cytosolic Ca2+ concentration which in turn followed by exit of 
KCl with osmotically obliged water leading  to cell shrinkage 203.  
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Figure 11:  Effect of chromium (VI) on Fluo3 ﬂuorescence in erythrocytes. 
a) Histogram of Fluo3 fluorescence in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 20 µM chromium (VI) (indicated 
as, +) 
b) Dose dependence of the effect of chromium (VI) on Fluo3 fluorescence. 
Arithmetic means ± SEM (n = 15) of the normalized Fluo3 fluorescence 
of erythrocytes exposed for 48 hours to plain Ringer solution (white 
bar) or to chromium (VI)  (black bars) at the indicated concentrations. 
*** (P < 0.001) indicate significant difference from values in control 
Ringer solution (ANOVA). 
 
 
 
Cell shrinkage is a hallmark of eryptosis, therefore cell volume was 
estimated utilizing forward scatter. The forward scatter was determined 
using flow cytometry. As shown in Figure 12, at concentrations ≥10 µM 
chromium (VI) treatment was substantially followed by a decrease of 
forward scatter . 
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Figure 12:  Effect of chromium (VI) on erythrocyte forward scatter. 
a) Histogram of forward scatter in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 20 µM chromium (VI) (indicated 
as, +). 
b) Effect of chromium (VI) on forward scatter. Arithmetic means ± SEM (n 
= 15) of the normalized forward scatter of erythrocytes exposed for 48 
hours to plain Ringer solution (white bar) or to chromium (VI) (black 
bars). ***P<0.001 indicate significant difference from values in control 
Ringer solution (ANOVA). 
 
 
 Cell membrane scrambling with subsequent increase of 
phosphatidylserine abundance at the cell surface is considered the 
second hallmark of eryptosis. Accordingly, Confocal imaging was 
performed to visualize eryptosis in the absence and presence of 20 µM 
chromium (VI) as a first step (Fig. 13). The number of annexin V 
positive erythrocytes in chromium (VI) treated cells was indeed higher 
than in untreated erythrocytes incubated for 48 hours in Ringer solution. 
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Figure 13: Confocal images of phosphatidylserine-exposing erythrocytes with or 
without chromium (VI) treatment. 
Confocal microscopy technique was used in tow forms, light microscopy (lower panels) 
and FITC-dependent fluorescence (upper panels) to visualise stained human 
erythrocytes with FITC-conjugated annexin-V post 48h incubation in Ringer solution 
without (left panels) and with (right panels) 20 µM chromium (VI). 
  
 
 
Phosphatidylserine exposing erythrocytes identification was 
achieved as a second step by exploiting annexin-V-binding in flow 
cytometry. As illustrated in Fig. 14a and b, the percentage of annexin-V-
binding erythrocytes post a 48 hours exposure to chromium (VI)  
increased, an effect reaching statistical significance at 10 μM chromium 
(VI)   concentration. 
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Figure 14: Effect of chromium (VI) on phosphatidylserine exposure. 
a) Histogram of annexin V-binding in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 20 µM chromium (VI) (indicated 
as ,+). 
b) Effect of chromium (VI) on phosphatidylserine exposure. Arithmetic 
means ± SEM (n = 15) of the percentage of annexin V-binding 
erythrocytes exposed for 48 hours to plain Ringer solution (white bar) 
or to chromium (VI) (black bars). For a purpose of comparison, 
arithmetic means ± SEM (n = 4) were used to express the percentage 
of hemolysis is shown as grey bars. **P<0.01, *** (P < 0.001) indicates 
significant difference from values in control Ringer solution (ANOVA). 
 
 
 The fluorescent annexin V access to phosphatidylserine could 
result from permeabilization of erythropcytes under hemolysis, in order 
to elucidate, whether chromium (VI) exposure leads to hemolysis, the 
estimated percentage of hemolysed erythrocytes was quantified from 
the released haemoglobin in the supernatant. As shown in Fig. 14b,  the 
exposure to chromium (VI) for 48 hours increased the hemoglobin 
concentration in the supernatant, an effect reaching statistical 
significance at 10μM chromium (VI) concentration. Hemolytic 
erythrocytes percentage is notably still almost one order of magnitude 
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smaller than the percentage of phosphatidylserine exposing 
erythrocytes (Fig. 14 b). 
 
 
To test whether chromium (VI)-induced increasing in the 
cytosolic Ca2+ concentration is indeed in charge of cell membrane 
scrambling and phosphatidylserine exposure harnessing Ca+2 entry, 
erythrocytes were exposed to 20 µM chromium (VI) in the nominal 
absence of extracellular Ca2+. As shown in Fig. 14c, the impact of 
chromium (VI) -induced phosphatidylserine exposure was significantly 
blunted but not abolished in the nominal absence of extracellular Ca2+. 
 
 
 
 
Figure 14c: Effect of chromium (VI) on phosphatidylserine exposure in the 
presence and absence of calcium. 
C) Annexin V-binding erythrocytes percentage is expressed with arithmetic 
means ± SEM (n = 8) post exposure for 48 hours to plain Ringer 
solution (white bars) or to 20 µM chromium (VI) (black bars) in the 
presence (left bars) and absence (right bars) of Ca2+ in extracellular 
fluid. **P<0.01, ***P<0.001 indicates significant difference from values 
  
 
3.  RESULTS 52 
in control Ringer solution (ANOVA). ### (P < 0.001) indicates 
significant difference from respective values in the presence of Ca2+ 
(ANOVA). 
 
 
The cell membrane scrambling post chromium (VI) exposure can be 
traced largely to an increase of intracellular Ca+2 activity. 
To investigate further whether phosphatidylserine exposure on the 
cell surface in erythrocytes incubated in serum would likewise be 
induced by chromium (VI). Exposure to 20µM chromium (VI) for 48h as 
shown in Figure 14d, annexin V binding increased in serum to a similar 
extent in erythrocytes incubated in Ringer solution. 
 
 
 
 
Figure 14d: Effect of chromium (VI) on phosphatidylserine exposure in 
Ringer or serum. 
D) annexin V-binding erythrocytes percentage expressed with arithmetic 
means ± SEM (n = 4) after a 48 h exposure with Ringer solution (left 
bars) or serum (right bars) without (white bar) or with (black bars) 20 
µM chromium (VI). ***P<0.001 indicates significant difference from the 
absence of chromium (VI) (ANOVA). 
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In the Serum, annexin V binding erythrocytes Percentage heads for 
to be somewhat higher than in the Ringer following exposure to 20-µM 
chromium (VI), a statistical comparison between them did not show any  
significant different. 
Cellular depletion of ATP is considered eryptosis stimulator 75, In the 
presence or absence of chromium (VI) the intracellular ATP 
concentration of erythrocytes was therefore quantified post incubation 
with chromium (VI). As illustrated in Figure 15, a 48 hours exposure of 
human erythrocytes to 20µM chromium (VI) resulted in a significant 
decrease of the cytosolic ATP concentration. Incubation in glucose-free 
solution served as a positive control (Fig. 15, grey bar). 
  
 
 
 
Figure 15: Effect of chromium (VI) on erythrocyte cytosolic ATP content. 
Cytosolic ATP concentration as a result of chromium (VI) effect on 
erythrocyte. ATP concentration were expressed with arithmetic means ± 
SEM (n = 4) post a 48 h incubation in Ringer solution without (white 
bar) or with (black bars) 20 µM chromium (VI), or in glucose-depleted 
Ringer solution (grey bar, minus glucose). **P<0.01, ***P<0.001 
indicates significant difference from control (absence of chromium (VI) 
and presence of glucose) (ANOVA) 
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Cell membrane scrambling and cell shrinkage could be a 
subsequent of ceramide enhancing203, which could thus, in theory, have 
a significant role in chromium (VI) effect. To determine ceramide 
formation, FITC-labelled anti-ceramide antibodies was used. A 48 hours 
exposure of erythrocytes in Ringer solution without (23.5 ± 1.9 a.u., n = 
4) and with (21.3 ± 2.4 a.u., n = 4) 20 µM chromium (VI) showed similar 
readings. 
 
 
3.2. Involvement of Rotenone in the erythrocyte cell 
membrane scrambling  
 
To test whether Rotenone increases the cytosolic free Ca2+ 
concentration of erythrocytes, Fluo-3 fluorescence measurements in 
FACS have been performed in red cells incubated for 48 hours either in 
the absence or presence of Rotenone (1-10 µM). As illustrated in Fig. 
16, the incubation of human erythrocytes in rotenone increased 
significantly the Fluo-3 fluorescence, pointing to an increase of cytosolic 
free Ca2+ concentration (Fig. 16). At 1 µM rotenone concentration a 
statistical significance could be detected. 
Red cells express Ca2+-sensitive K+ channels suggesting that 
elevated cytosolic Ca2+ activity triggers the loss of KCl and osmotically 
obliged water and thus leads to cell shrinkage, which should be 
apparent from a decrease of forward scatter in FACS analysis. 
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Figure 16: Effect of rotenone on erythrocyte cytosolic Ca2+ concentration. 
A) Histogram of Fluo3 fluorescence in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 10 µM rotenone (indicated as, +) 
B) Dose dependence of the effect of rotenone on Fluo3 fluorescence. 
Arithmetic means ± SEM (n = 10) of the normalized Fluo3 fluorescence 
of erythrocytes exposed for 48 hours to plain Ringer solution (white bar) 
or to rotenone (black bars) at the indicated concentrations. *p < 0.05, 
***p < 0.001 indicate significant difference from values in control Ringer 
solution (ANOVA). 
 
 
 
Fig. 17 indeed demonstrates that exposure to rotenone at 
concentrations ≥ 2.5 µM led to a decrease of erythrocyte forward 
scatter in FACS analysis data. At 2.5 µM rotenone concentration a 
statistically significance could be detected. 
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Figure 17: Effect of rotenone on erythrocyte forward scatter. 
A) Histogram of forward scatter in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 10 µM rotenone (indicated as, +). 
B) Effect of rotenone on forward scatter. Arithmetic means ± SEM (n = 10) 
of the normalized forward scatter of erythrocytes exposed for 48 hours 
to plain Ringer solution (white bar) or to rotenone (black bars). **p < 
0.01, ***p < 0.001 indicate significant difference from values in control 
Ringer solution (ANOVA). 
 
 
 
 
Cell membrane scrambling with subsequent phosphatidylserine 
exposure at the erythrocytes surface is considered as result of cytosolic 
Ca2+ concentration augmentation, which should further do boosting for 
erythrocyte annexin V binding.  Therefore, a new set of experiments  
was conducted to investigate whether rotenone has any impact 
translated into cell membrane scrambling. Fig. 18 shows that a 48 
hours exposure to rotenone indeed enhanced the percentage of 
annexin V binding erythrocytes determined by FACS analysis. The 
concentration needed for a significant increase of the percentage of 
annexin V binding erythrocytes was 1 µM.  
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In order to elucidate, whether rotenone exposure leads to 
hemolysis, the estimated percentage of hemolysed erythrocytes was   
quantified from the released haemoglobin in the supernatant. As shown 
in Fig. 18b, exposure to rotenone for 48 hours increased the 
hemoglobin concentration in the supernatant, an effect reaching 
statistical significance at 2.5 μM rotenone concentration.  
 
 
 
 
 
Figure 18: Effect of rotenone on phosphatidylserine exposure and hemolysis. 
A) Histogram of annexin V-binding in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 10 µM rotenone (indicated as ,+). 
B) Effect of rotenone on phosphatidylserine exposure. Arithmetic means ± 
SEM (n = 10) of the percentage of annexin V-binding erythrocytes 
exposed for 48 hours to plain Ringer solution (white bar) or to rotenone 
(black bars). For a purpose of comparison, arithmetic means ± SEM (n 
= 4) were used to express the percentage of hemolysis presented as 
grey bars. *p < 0.05, ***p < 0.001 indicates significant difference from 
values in control Ringer solution (ANOVA). 
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To explore the significance of rotenone-induced Ca2+ entry for PS-
exposure and cell shrinkage, the effects of rotenone were tested in the 
nominal presence and absence of extracellular Ca2+ by exposing the 
erythrocytes to 10 µM rotenone. As shown in Fig. 19, the stimulation of 
phosphatidylserine exposure by rotenone was significantly blunted in 
the absence of extracellular Ca2+. 
 
 
 
Figure 19: Effect of Ca
2+
 withdrawal on rotenone- induced annexin-V-
binding. 
Annexin V-binding erythrocytes percentage is expressed with arithmetic 
means ± SEM (n = 8) post exposeure for 48 hours to plain Ringer 
solution (white bars) or to 10  µM rotenone (black bars) in the presence 
(left bars) and absence (right bars) of Ca2+ in extracellular fluid. **p < 
0.01, ***p < 0.001 indicates significant difference from values in control 
Ringer solution (ANOVA). ##p < 0.01  indicates significant difference 
from respective values in the presence of Ca2+ (ANOVA). 
 
 
 
 
Since the percentage of phosphatidylserine exposing 
erythrocytes was remain significantly higher in the presence than in the 
absence of rotenone, therefore, erythrocyte membrane scrambling 
triggering in a big part but not absolutely due to Ca2+ entry, this end 
discloses a new involved mechanism. 
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Removal of extracellular Ca2+ did not fully abrogate the 
breakdown of phosphatidylserine asymmetry of the cell membrane 
following rotenoe treatment. As sensitivity of cell membrane scrambling 
to [Ca2+]I  is enhanced by ceramide, additional experiments were 
performed to determine the effect of rotenone on ceramide formation.  
FITC-labeled anti-ceramide antibodies were employed to identify 
ceramide abundance at the erythrocyte surface. Figure. 20 illustrated a 
slightly but significantly increase of ceramide formation post (10µM) 
rotenone exposing, this end discloses a non-Ca2+ mediated mechanism 
involvement.  
 
 
 
Figure 20: Effect of rotenone on ceramide formation. 
 
 
A) Histogram of anti-ceramide FITC-fluorescence in a representative 
experiment of erythrocytes from healthy volunteers exposed for 48 
hours to Ringer solution without (indicated as, -) or with (indicated as, +) 
10 µM rotenone. 
B) Arithmetic means ± SEM (n = 4) were used to express ceramide 
abundance in erythrocytes exposed for 48 hours to Ringer solution 
without (white bar) or with (black bar) 10 µM rotenone. *p < 0.05 
indicates significant difference from values in control Ringer solution (t-
test) 
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3.3. Participation of Apigenin in eryptosis 
 
Both cell shrinkage and cell membrane scrambling could be 
triggered by increase in the cytosolic Ca2+ activity92. Accordingly, Fluo3 
fluorescence was employed to estimate the cytosolic Ca2+ 
concentration. As illustrated in figure 21 A,B, graded increases of Fluo3 
fluorescence was the consequence of human erythrocytes treatment 
with apigenin, Apigenin Impact reached statistically significant at the 
employed concentrations (≥1 μM) indicating that apigenin increases 
cytosolic Ca2+ concentration  
 
 
 
Figure 21: Effect of apigenin on erythrocyte cytosolic Ca2+ concentration. 
C) Histogram of Fluo3 fluorescence in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 15 μM apigenin (indicated as, +) 
A) Dose dependence of the effect of apigenin on Fluo3 fluorescence. Arithmetic 
means ± SEM (n = 12−16) of the normalized Fluo3 fluorescence of erythrocytes 
exposed for 48 hours to plain Ringer solution (white bar) or to apigenin (black 
bars) at the indicated concentrations. * (p < 0.05) and *** (p < 0.001) indicate 
significant difference from values in control Ringer solution (ANOVA 
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One of the hallmarks of eryptosis is cell shrinkage. To determine, 
whether apigenine could trigger eryptosis in erythrocytes executing  
alterations in cell volume which is estimated by forward scatter analysis 
in FACS. As illustrated in figure 22, graded decrease in forward scatter 
reflexed respective decreases in cell volumes following apigenin 
treatment. Apigenin impact reached statistically significant at applied 
concentrations (≥1 μM). 
 
 
 
 
Figure 22: Effect of apigenin on erythrocyte forward scatter. 
A) Histogram of forward scatter in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 15 μM apigenin (indicated as, +). 
B) Effect of apigenin on forward scatter. Arithmetic means ± SEM (12−16) 
of the normalized forward scatter of erythrocytes exposed for 48 hours 
to plain Ringer solution (white bar) or to apigenin (black bars). * p < 
0.05 and *** p < 0.001 indicate significant difference from values in 
control Ringer solution (ANOVA). 
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A further hallmark of eryptosis is cell membrane scrambling, leading 
to PS exposure at the cell surface. Annexin V-binding was used to 
quantify PS-exposing erythrocytes by FACS analyis. As shown in figure 
23A, graded increases in the percentage of annexin V binding 
erythrocytes post a 48 h treatment with apigenin. Thus, apigenine 
impact could reach statistical significance at ≥5 μM. 
Apigenin could cause direct lysis of erythrocytes. To test this 
possibility, the percentage of lysed erythrocytes was determined 
following a 48h exposure to apigenin. As shown in figure 23B, 
hemoglobin concentration measurement displayed a slightly increase in 
the supernatant without reaching statistical significance. 
 
 
 
Figure 23: Effect of apigenin on phosphatidylserine exposure. 
A) Histogram of annexin V-binding in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 15 μM apigenin (indicated as ,+). 
B) Effect of apigenin on phosphatidylserine exposure. Arithmetic means ± 
SEM (n = 12-16) of the percentage of annexin V-binding erythrocytes 
exposed for 48 hours to plain Ringer solution (white bar) or to apigenin 
(black bars). For a purpose of comparison, arithmetic means ± SEM (n 
= 4) were used to express the percentage of hemolysis is shown as 
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grey bars. * p < 0.05 and *** p < 0.001  indicates significant difference 
from values in control Ringer solution (ANOVA). 
 
 
 
To test whether apigenin -induced increase in the cytosolic Ca2+ 
concentration is indeed accounts for cell membrane scrambling and 
phosphatidylserine exposure, Erythrocytes were exposed to 15 µM 
apigenin in the nominal absence of extracellular Ca2+. As shown in Fig. 
24, apigenin -induced phosphatidylserine exposure, where its affect 
blunted significantly in the nominal absence of extracellular Ca2+ 
confirming the role of Ca2+ entry in eryptosis launching. 
 
 
 
       Figure 24: Effect of Ca2+ withdrawal on apigenin- induced annexin V binding. 
Annexin V-binding erythrocytes percentage was expressed with 
arithmetic means ± SEM (n = 8) post exposeure for 48 hours to plain 
Ringer solution (white bars) or to 15 μM apigenin (black bars) in the 
presence (left bars) and absence (right bars) of Ca2+ in extracellular 
fluid. ***p < 0.001 indicates significant difference from values in control 
Ringer solution (ANOVA). ### p < 0.001  indicates significant difference 
from respective values in the presence of Ca2+ (ANOVA). 
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The percentage of annexin V binding erythrocytes was unable to 
be completely abrogated in the nominal absence of Ca2+ post apigenin 
exposure, this end discloses indeed additional mechanisms 
involvement in the stimulation of erythrocyte membrane scrambling by 
apigenin.  
 To test whether γ-aminobutyric acid (GABA) able to make any 
modification on apigenin-induced phosphatidylserine exposure in 
erythrocytes, extra experiments were applied for this pupose. Thus,  
incubation of erythrocytes were taken place in the presence and 
absence of 15 μM apigenin and in the presence and absence of 15 μM 
GABA as well. The percentage of annexin V binding erythrocytes 
increased significantly from 2.7 ± 0.5% (n = 6) in the absence of 
apigenin to 12.3 ± 1.8% (n = 6) in the presence of 15 μM apigenin.  No 
significant modification in annexin V binding percentage of incubated 
erythrocytes was detectable post addition of 15 μM GABA, in the 
absence of apigenin (3.5 ± 0.9%, n = 6) nor in the presence of 15 μM 
apigenin (12.1 ± 2.2%, n = 6). 
 Further experiments explored whether the PS-exposure 
triggered by apigenin is reversible or not. Using annexin V binding, PS-
exposure was identified after 48 h incubation, Incubated erythrocytes 
for 48 h with exposure to 15 μM apigenin (19.6 ± 2.3%, n = 4) showed 
significantly higher PS exposure in comparison to those incubated in 
the absence of apigenin (3.2 ± 0.5%, n = 4). Tow further aliqutes were 
taken from the samples, 4 times with Ringer solution was washed the 
first one and posteriorly incubated for an additional 24 h, while the 
second aliquot was not washed and only was incubated for an extra 24 
h. The PS exposure in the washed aliquot (34.8 ± 2.9%, n = 4) after 72 
h did not show any significant differ in comparison to the unwashed one 
(32.9 ± 4.3%, n = 4) pointing to irreversibile impact of apigenin-induced 
phosphatidylserine exposure. 
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Cell membrane scrambling and cell shrinkage could be a 
subsequent of ceramide enhancing203, which could thus, in theory, have 
a significant role in apigenine effect. To determine ceramide formation, 
FITC-labelled anti-ceramide antibodies was used. As shown in Figures 
25A and 25B, a 48 h exposure to Ringer with 15 μM apigenin presented 
significantly higher ceramide-dependent fluorescence in comparison to 
those incubated in Ringer solution without apigenin. Thus, apigenin 
could significantly enhance ceramide formation. 
 
 
 
 
Figure 25. Effect of apigenin on ceramide formation. 
A) Histogram of anti-ceramide FITC-fluorescence in a representative 
experiment of erythrocytes from healthy volunteers exposed for 48 
hours to Ringer solution without (indicated as, -) or with (indicated as, +) 
15 μM apigenin. 
B) Arithmetic means ± SEM (n = 4) were used to express ceramide 
abundance in erythrocytes exposed for 48 hours to Ringer solution 
without (white bar) or with (black bar) 15 μM apigenin. ** p < 0.01 
indicates significant difference from values in control Ringer solution (t-
test) 
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Cellular depletion of ATP is considered eryptosis stimulator 75, In the 
presence or absence of apigenin, the intracellular ATP concentration of 
erythrocytes was therefore quantified post incubation with apigenin. As 
illustrated in Figure 26, a 48 hours exposure of human erythrocytes to 
15µM apigenin resulted in a significant decrease of the cytosolic ATP 
concentration. Incubation in glucose-free solution served as a positive 
control. 
 
 
 
 
       Figure 26: Effect of apigenin on erythrocyte cytosolic ATP content. 
Cytosolic ATP concentration as a result of apigenin effect on 
erythrocyte. ATP concentration were expressed with arithmetic means ± 
SEM (n = 4) post a 48 h incubation in Ringer solution without (white 
bar) or with (black bars) 15 μM apigenin, or in glucose-depleted Ringer 
solution (grey bar, minus glucose). * (p < 0.05) and ** (p < 0.01) 
indicates significant difference from control (absence of apigenin and 
presence of glucose) (ANOVA) 
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3.4. Honokiol in the triggering of erythrocyte cell membrane 
scrambling 
 
The present study addressed the effect of Honokiol on eryptosis. 
Cytosolic Ca2+ concentration ([Ca2+]i) was determined utilizing Fluo3 
fluorescence in an attempt to elucidate the mechanisms underlying the 
triggering of erythrocyte shrinkage and cell membrane scrambling 
following Honokiol exposure. To this end, erythrocytes were loaded with 
Fluo3-AM and Fluo3 fluorescence determined in FACS analysis 
following incubation in Ringer solution without or with Honokiol (1-15 
µM). As illustrated in Figure 27. statistically significant increase of Fluo3 
fluorescence as a result of human erythrocytes treatment with Honokiol 
at only a concentration of  15 µM, while up to 10 µM honokiol remained 
without significant effect on Fluo3 fluorescence. Observations pointing 
to an increase of cytosolic Ca2+ concentration. Ca2+ sensitive K+ 
channels is activated as a result of an increase of cytosolic Ca2+ 
concentration which in turn followed by exit of KCl with osmotically 
obliged water leading  to cell shrinkage 203 
In the presence of the calcium ionophore ionomycin as a positive 
control we measured Fluo3 fluorescence, Erythrocytes were treated 
with 1 µM ionomycin which was enough to enhance significantly Fluo3 
fluorescence from 21 ± 0.9 to 61 ± 2.0 (a.u., n = 4). 
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Figure 27: Effect of honokiol on erythrocyte cytosolic Ca2+ concentration 
a) Histogram of Fluo3 fluorescence in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 15 µM honokiol (indicated as, +) 
b) Dose dependence of the effect of honokiol on Fluo3 fluorescence. 
Arithmetic means ± SEM (n = 15) of the normalized Fluo3 fluorescence 
of erythrocytes exposed for 48 hours to plain Ringer solution (white 
bar) or to Honokiol (black bars) at the indicated concentrations. ***p < 
0.001 indicate significant difference from values in control Ringer 
solution (ANOVA) 
 
 
 
Cell shrinkage is a hallmark of eryptosis, therefore cell volume was 
estimated utilizing forward scatter. The forward scatter was determined 
using flow cytometry. As shown in Figure 28, honokiol treatment was 
substantially followed by a decrease of forward scatter and reached 
statistical significance at a concentration ≥5 µM. Susequently, honokiol 
decreased erythrocyte volume. A further experiment was performed to 
bolster our results, where the accurate diameter of erythrocyte treated 
with and without honokiol was determined. As illustrated in the Figure 
28C, a significant decrease in the erythrocyte diameter after treatment 
with 15µM honokiol could recorded. 
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           Figure 28: Effect of honokiol on erythrocyte forward scatter and diameter 
a) Histogram of forward scatter in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 15 µM honokiol (indicated as, +). 
b) Effect of chromium (VI) on forward scatter. Arithmetic means ± SEM (n 
= 15) of the normalized forward scatter of erythrocytes exposed for 48 
hours to plain Ringer solution (white bar) or to honokiol (black bars). 
***P<0.001 indicate significant difference from values in control Ringer 
solution (ANOVA). 
c) Arithmetic means ± SEM (n = 4) were used to express the normalized 
erythrocyte diameter post exposure for 48 h to Ringer solution without 
(white bar) or with (black bars) honokiol (15 µM). *** (p<0.001) indicate 
significant difference from the absence of honokiol (t test). 
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 Cell membrane scrambling with subsequent phosphatidylserine 
exposure at the erythrocytes surface is considered as result of cytosolic 
Ca2+-concentration augmentation, which should further do boosting for 
erythrocytic annexin V binding.  Therefore, a new set of experiments 
investigated whether honokiol has any impact followed by cell 
membrane scrambling. Fig. 29 shows that a 48 hours exposure to 
honokiol indeed enhanced the percentage of annexin V binding 
erythrocytes determined by FACS analysis. The concentration needed 
for a significant increase of the percentage of annexin V binding 
erythrocytes was 5µM. Subsequently, a breakdown of 
phosphatidylserine asymmetry of the cell membrane was a result of 
honokiol exposure which is followed by with phosphatidylserine 
exposure at the cell surface. Honokiol performed a time-dependent 
increase in phiosphatidylserine exposure (Figure 29C). 
 
in order to elucidate, whether honokiol exposure leads to 
hemolysis, the estimated percentage of hemolysed erythrocytes was   
quantified from the  released haemoglobin in the supernatant. As shown 
in Fig. 29b, exposure to honokiol for 48 hours increased the hemoglobin 
concentration in the supernatant, an effect reaching statistical 
significance at 10-μM chromium (VI) concentration. Hemolytic 
erythrocytes percentage is notably still almost one magnitude smaller 
than the percentage of phosphatidylserine exposing erythrocytes (Fig. 
29 b). 
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    Figure 29: Effect of honokiol on phosphatidylserine exposure and hemolysis 
A) Histogram of annexin V-binding in a representative experiment of 
erythrocytes from healthy volunteers exposed for 48 hours to plain 
Ringer solution (indicated as, -) or to 15 µM honokiol (indicated as ,+). 
B) Effect of chromium (VI) on phosphatidylserine exposure. Arithmetic 
means ± SEM (n = 15) of the percentage of annexin V-binding 
erythrocytes exposed for 48 hours to plain Ringer solution (white bar) or 
to honokiol (black bars). For a purpose of comparison, arithmetic 
means ± SEM (n = 4) were used to express the percentage of 
hemolysis is shown as grey bars. * (p<0.05), ** (p<0.01), *** (p<0.001) 
indicates significant difference from values in control Ringer solution 
(ANOVA). 
C) Arithmetic means ± SEM (n = 4) were used to express erythrocyte 
annexin-V-binding post exposure for 6 - 48 h to Ringer solution without 
(white triangles) or with (black squares) Honokiol (15 µM). * (p 
  
 
3.  RESULTS 72 
<0.05),*** (p <0.001) indicates significant difference from the absence 
of Honokiol (t test). 
 
 
DMSO was the solvent of honokiol, where we studied the effect of 
DMSO on PS exposure. No significant effect of DMSO could modify PS 
exposure following erythrocytes treatment with 0.15% DMSO. PS 
exposure values ranged between 2.6 ± 0.5% in the absence of DMSO 
and  2.8 ± 0.4%  in the presence of DMSO (n=4).   
Cell membrane scrambling with subsequent increase of 
phosphatidylserine abundance at the cell surface is considered the 
second hallmark of eryptosis. Accordingly, Confocal imaging was 
performed to visualize eryptosis in the absence and presence of 15 µM 
honokiol (Fig. 30). The number of annexin V positive erythrocytes in 
honokiol treated cells was indeed higher than in untreated erythrocytes 
incubated for 48 hours in Ringer solution. 
 
 
           
Figure 30: Confocal images of phosphatidylserine exposing erythrocytes with or 
without honokiol treatment 
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Confocal microscopy technique was used in tow forms, light microscopy (lower 
panels) and FITC-dependent fluorescence (upper panels) to visualise stained 
human erythrocytes with FITC-conjugated annexin-V post 48h incubation in 
Ringer solution without (left panels) and with (right panels) 15 µM Honokiol.   
 
 
To test whether honokiol-induced increase in the cytosolic Ca2+ 
concentration is indeed in charge of cell membrane scrambling and 
phosphatidylserine exposure, Erythrocytes were exposed to 15µM 
honokiol for a 48h in the nominal absence of extracellular Ca2+. As 
shown in Fig. 31, honokiol induced phosphatidylserine exposure, where 
the affect was significantly blunted in the nominal absence of 
extracellular Ca2+. 
 
 
 
 
 
        Figure 31: Effect of Ca2+ withdrawal on honokiol- induced annexin-V-binding 
Annexin V-binding erythrocytes percentage was expressed with 
arithmetic means ± SEM (n = 8) post exposure for 48 hours to plain 
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Ringer solution (white bars) or to 15 µM honokiol (black bars) in the 
presence (left bars) and absence (right bars) of Ca2+ in extracellular 
fluid. ***P<0.001 indicates significant difference from values in control 
Ringer solution (ANOVA). ## (p<0.01) indicates significant difference 
from respective values in the presence of Ca2+ (ANOVA). 
 
 
 
 To explore whether calcium-dependent PS exposure induced by 
honokiol is further enhanced by ionomycin, additional experiment were 
performed exposing erythrocytes to 15 µM Honokiol in the presence 
and absence of the calcium ionophore ionomycin. As shown in Figure 
32, erythrocytes exposed to both honokiol and 1µM ionomycin have 
significantly higher intracellular calcium activity than those exposed to 
honokiol alone.  
 
 
 
 
Figure 32: Effect of ionomycin on honokiol- induced annexin-V-binding 
Annexin V-binding erythrocytes percentage expressed with arithmetic 
means ± SEM (n = 4) after a 1 h exposure with Ringer solution without 
(white bar) or with (black bars) 15 µM honokiol in the absence (left bars) 
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and presence (right bars) of ionomycin (1 µM) ***P<0.001 indicates 
significant difference from the absence of honokiol (ANOVA) ### 
(p<0.001) indicates significant difference from the respective values in 
the absence of ionomycin. 
 
 
 
 
 
As a sensitivity of cell membrane scrambling to [Ca2+]I  is 
enhanced by ceramide, additional experiments were performed to 
determine the effect of honokiol on ceramide formation.  FITC-labeled 
anti-ceramide antibodies was employed to identify ceramide abundance 
at the erythrocyte surface. Figure. 33 illustrated a slightly but 
significantly increase of ceramide formation post (15µM) honokiol 
exposing, this end discloses a non-Ca2+ mediated mechanism 
involvement.  
 
 
 
Figure 33: Effect of honokiol on ceramide formation. 
A) Histogram of anti-ceramide FITC-fluorescence in a representative 
experiment of erythrocytes from healthy volunteers exposed for 48 
hours to Ringer solution without (indicated as, -) or with (indicated as, +) 
15 µM honokiol. 
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B) Arithmetic means ± SEM (n = 4) were used to express ceramide 
abundance in erythrocytes exposed for 48 hours to Ringer solution 
without (white bar) or with (black bar) 15 µM honokiol.. *p < 0.05 
indicates significant difference from values in control Ringer solution (t-
test) 
 
 
 
 
 
  
 
4.  DISCUSSION 77 
 
 
 
 
 
 
Chapter 4 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
  
 
4.  DISCUSSION 78 
Chapter 4 
 
4.  DISCUSSION 
4.1. Modulation of erythrocyte survival by Hexavalent 
Chromium 
 Unconventional effect of chromium (VI) is disclosed by the present study, 
where chromium (VI) influences erythrocyte survival by triggering eryptosis, the 
suicidal death of erythrocytes. Treatment of human erythrocytes with chromium 
(VI) is followed by decrease of cell volume and cell membrane scrambling with 
translocation of phosphatidylserine in the cell membrane from inside to the 
outer surface 11,  phosphatidylserine translocation is considered a crucial signal 
detected by  special receptors in macrophages, which in turn bind the eryptotioc 
erythrocytes, engulf and degrade them 100. 
Our observations have shown that Chromium (VI) is able to induce 
hemolysis, however, its impact pervaded only a restricted percentage of 
erythrocytes. The affecting concentrations are well in the range of those 
achieved during chromium intoxication in vivo109. In severe chromium 
intoxication some high values have been detected, which approach to 42 µM 
204, on the other hand healthy individuals showed chromium serum 
concentrations less than 0.1 µM  205. 
The cell membrane scrambling following chromium (VI) exposure is most 
likely a result of  Ca2+ entry with ensuing augment of cytosolic Ca2+ activity, 
where previous observations described the increasing  of cytosolic Ca2+ activity 
as a powerful stimulator of cell membrane scrambling 37, 92, 96. Supposedly, 
chromium (VI) activates nonselective cation channel, the molecular identity of 
this channel is still incompletely understood, but somehow involves TRPC6 77. 
This recent Ca2+ increase leads to activation Ca2+ sensitive K+ channel, where 
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opening of those channels fosters exit of K+ following its chemical gradient, 
resulting in cell membrane hyperpolarisation, Cl-  exit and thus cellular loss of 
KCl with  osmotically obliged water 206, Accordingly, chromium (VI)  provided a 
decrease of forward scatter, an observation reflecting cell shrinkage. 
Chromium (VI) has been proved already its effective cellular impact 109, 118, 
207, 208, also the cation channel has been reported to be activated by oxidative 
stress 209. 
The nominal absence of extracellular Ca2+ significantly blunted, but did not 
fully abrogate the scrambling effect of chromium (VI), indicating that Chromium 
(VI) has to induce cell membrane scrambling not  by Ca2+ entry but also using 
some additional further mechanism involved in the apoptosis.  
 
 ATP depletion in the erythrocyte is an important factor in eryptosis 
signaling 75. According to our observations, chromium (VI) decreases cytosolic 
ATP concentration, this lack of energy assumably plays an important role by 
eryptosis stimulation. The energy depletion here is considered a temperate 
stimulator of eryptosis, thus it has not the fully upper hand by strong stimulation 
of cell membrane scrambling. Glycolysis could be targeted in erythrocyte by 
chromium (VI), which is working on ATP generation disruption; its action here 
could reflect its interference with glycolytic flux and thus on ATP levels. 
Ceramide can also stimulate cell membrane scrambling 210,  where 
sensitizes the cell to the proeryptotic effects of increased cytosolic Ca2+ activity 
98. Ceramide formation is stimulated by platelet activating factor (PAF), which 
activates a sphingomyelinase leading to the breakdown of sphingomyelin 211.  
Apoptosis may be triggered in same way by ceramide in nucleated cells 212. 
However, chromium (VI) could not significantly alter ceramide abundance. 
Thus, ceramide formation supposedly has no hand by  the stimulation of 
erythrocyte cell membrane scrambling by chromium (VI). 
 A positive merit of eryptosis, that erythrocytes are removed from 
circulating blood without release of hemoglobin into plasma. Exposure to 
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chromium as several other triggers of eryptosis could keep the most treated 
erythrocytes undergoing eryptosis, instead of hemolysis. Macrophages  are 
usually recognize exposing erythrocytes phosphatidylserine, which clear 
defective erythrocytes from circulating blood prior to hemolysis. 
 
The rupture of cell membrane is the inevitable result of progressing cell 
swelling, ultimately followed by release of cellular hemoglobin, which is filtered 
in renal glomerula with subsequent precipitation in renal tubular fluid and 
occludes renal tubules 213. 
 
Anemia could be defined, the extent at which enhancing erythrocyte 
formation cannot compensate the progressing loss of them, accelerated 
eryptosis may, however, reduce the total circulating erythrocytes, a 
consequence of accelerated eryptosis is the development of anemia (Lang, 
Gulbins et al. 2008). Moreover, phosphatidylserine-exposing erythrocytes may 
adhere to the vascular wall214, 215  and further stimulate blood clotting214, 216, 217 . 
Accordingly, enhanced eryptosis can impair microcirculation and launch 
involvement in the vascular injury of metabolic syndrome 218 Thus, excessive 
eryptosis may become pathophysiologically relevant. 
 
 Plenty substances can act as eryptosis stimulators 43, 46, 63, 219, 220. The 
current findings highligted the effect of chromium (VI) on enucleated cells, 
therefore, not only trigger apoptosis of nucleated cells but is similarly effective in 
the absence of nuclei and mitochondria. Finaly, ATP depletion, Ca2+ entry are 
stimulated by chromium (VI) in erythrocytes, which give rise to cell membrane 
scrambling and cell shrinkage. 
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4.2. Involvement of Rotenone in the erythrocyte cell membrane 
scrambling  
Triggering of suicidal erythrocyte death or eryptosis is an incoming effect 
of rotenone, it has been brought to light by the present observations, i.e. cell 
membrane scrambling, cell shrinkage and phosphatidylserine exposure at the 
cell surface are a result of human erythrocytes exposure to rotenone. 
Phosphatidylserine-exposing erythrocytes are engulfed by macrophages 
equipped with phosphatidylserine receptors100  and thus eliminated from 
circulating blood 221. Earlier observations provided that rotenone plasma 
concentrations range from  0.4  to  0.9 µM  posterior intraperitoneal       
injections of 2 mg/kg per day222.  To bring out the effect in our study, it was 
required a concentration 1 µM, corresponding to approximately 0.4 mg/kg. 
Applied dosages on animals are ranging between 1 and 10 mg/kg 222 223 224, 225 
226. Rotenone plasma concentrations ranged between 1 and 2 µM have been 
determined following subcutaneous injection of encapsulating microspheres 
rotenone227.  All the above-mentioned observations indicated well relevant 
confirmation for rotenone treatment in vivo. 
Our study revealed that cytosolic Ca2+ activity is elevated by rotenone, 
this increase can be attributable to the involvement of Ca2+ permeable cation 
channels TRPC6 which has proved already in previous other observations its 
implication in the cation current variations and Ca2+ entry into erythrocytes77. 
The cation channels also showed a positive response to oxidative stress209. 
  Gardos channels (Ca2+-sensitive K+ channels) are activated as a result 
of cytosolic Ca2+ augmenting 228 leading to intracellular K+ loss following its 
chemical gradient, hyperpolarization and exit of Cl- ions, these events are 
usually associated concurrently with a loss of osmotically obliged water ,thus 
cell shrinkage37. As a matter of fact, rotenone decreases the forward scatter, as 
findings reflect cell shrinkage, which was apparent in our observations.    
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 The effect of rotenone on cell membrane scrambling results at least in 
part from an increase of cytosolic Ca2+ concentration, which is well known to 
trigger erythrocyte membrane scrambling resulting in phosphatidylserine 
exposure at the erythrocyte surface 37, 92, 96.  Rotenone- induced cell membrane 
scrambling is significantly blunted by removal of extracellular Ca2+, indicating  
that rotenone is at least partially effective by stimulating Ca2+ -entry from 
extracellular space. Removal of extracellular Ca2+ does, however, not fully 
abrogate the rotenone induced cell membrane scrambling, indicating that one or 
more additional mechanisms may be involved in the stimulation of cell 
membrane scrambling by rotenone.  
Besides stimulating Ca2+ entry, rotenone triggers the formation of 
ceramide, which is known to enhance the sensitivity of the scrambling 
machinery to [Ca2+]i 229 . Ceramide is produced by a sphingomyelinase, which is 
activated by platelet activating factor229.  Ceramide similarly triggers apoptosis 
of nucleated cells212. Ceramide thus contributes to the pathophysiology of 
several clinical disorders, such as, Wilson’s disease 230, multiple sclerosis 231, 
major depression 212, Parkinson’s disease 232, Alzheimer’s disease 212, 233, 
cardiovascular disease 234, cystic fibrosis 235, lung inflammation, fibrosis and 
infection 236. 
Excessive eryptosis may, however, be pathophysiologically relevant 237. 
Phosphatidylserine exposing erythrocytes further adhere to endothelial 
CXCL16/SR-PSO 238. The adherance of phosphatidylserine exposing 
erythrocytes to the vascular wall is expected to compromise microcirculation214, 
215, 238, 239, 240 and foster blood clotting 214, 216, 217. Thus, rotenone-induced 
 exaggerated eryptosis increases the risk of thrombosis. Phosphatidylserine 
exposing erythrocytes are further engulfed and thus cleared from circulating 
blood 203, 218. Accordingly, excessive eryptosis may lead to anemia 203, 218. 
In conclusion, Ca2+ entry and ceramide formation are the result of 
exposing erythrocytes to rotenone with inevitable consequences represented in 
triggering of cell membrane scrambling and cell shrinkage. Thus, the suicidal 
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death of erythrocytes is stimulated by retonene regardless the presence of 
mitochondria. 
 
4.3.  Participation of Apigenin in eryptosis 
The current study discloses an innovative function of apigenin, i.e. the 
stimulation of eryptosis. Specifically, apigenin activates cation channels leading 
to influx of Ca2+, cell shrinkage, and phosphatidylserine exposure at the 
erythrocyte surface. The range of concentrations observed in vivo included our 
concentration needed to trigger cell membrane scrambling and PS exposure. 
Stimulating Ca2+ entry with further increase of cytosolic Ca2+ activity is 
the first pathway employed by apigenin to demonstrate its effective impact on 
erythrocytes. Cation nonselective channels are supposedly atctivated by 
apigenin, which have formerly been shown to involve TRPC6 77. Oxidative 
stress is a considered a main trigger of cation channel activity 209. 
Phosphatidylserine exposure at the erythrocyte surface as shown previously 37, 
92, 96 is a result of cytosolic Ca2+ activity increasing which in turn stimulates cell 
membrane scrambling, The scrambling effect of apigenin is significantly blunted 
in the nominal absence of extracellular Ca2+, indicating that apigenin triggered 
cell membrane scrambling at least partialy by augmenting  Ca2+ entry. However, 
even in the nominal absence of Ca2+, apigenin could significantly enhance 
phosphatidylserine exposure. Thus, apigenin must have been effective by 
additional mechanisms.   
 
Apigenin treatment was indeed followed by an increase of ceramide 
formation, an effect never shown before.  Ceramide stimulates cell membrane 
scrambling in erythrocytes and apoptosis of nucleated cells 98, 210, which is 
similarly known to trigger apoptosis of nucleated cells212.  
 
Excessive ceramide formation participates in the pathophysiology of 
diverse diseases, such as lung inflammation, fibrosis and infection236, cystic 
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fibrosis 235, cardiovascular disease 234, 241, Wilson’s disease230. Thus, ceramide 
formation supposedly involved in the stimulation of cell membrane scrambling. 
  
Further mechanisms known to trigger eryptosis include energy depletion 
75. As a matter of fact, apigenin indeed decreased cytosolic ATP concentration, 
an effect again boost the stimulation of eryptosis. Erythrocyte ATP generation is  
somehow dependent on glycolysis, where the effect of apigenin on cytosolic 
ATP levels may reflect an interference with glycolytic flux  either by utilization or 
through impaired formation of ATP. In theory, energy consuming associated   
with Ca2+ export during cation nonselective channels activation could 
considered as direct cause of ATP depletion. However, removal of extracellular 
Ca2+ could not blunt the decreasing of cytosolic Ca2+  concentration post 
apigenin treatment. 
 
Apigenin increased cytosolic Ca2+ activity which is expected to result in 
cell shrinkage by activation of Ca2+-sensitive K+ channels 20, 228. The opening of  
those channels leads exit of K+ following its chemical gradient, cell membrane 
hyperpolarization, Cl- exit due to increased electrical driving force and thus 
cellular loss of KCl with osmotically obliged water 242.  
 
Apigenin as wide range of xenobiotics proved its proeryptotic activity  by 
triggering eryptosis 219, 220. Morover, eryptosis is enhanced in diverse clinical 
disorders 203, including diabetes 243, 244, renal insufficiency 67, hemolytic uremic 
syndrome245,  sepsis246, sickle cell disease247.malaria,248, 249, Wilson’s 
disease230,  iron deficiency221, phosphate depletion250 and presumably 
metabolic syndrome251. 
 
In general, erythrocytes which expose phosphatidylserine must be  
quickly cleared from circulating blood, Anemia could result from excessive 
eryptosis 218 .Moreover, microcirculation could be impaired by the adherence 
phosphatidylserine-exposing erythrocytes to the vascular wall214, 240 and by 
stimulating blood clotting214, 217. 
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Ca2+ entry, ceramide formation and ATP depletion all are triggered by 
apigenin,  which is ultimately launch  eryptosis, characterized by cell shrinkage 
and cell membrane scrambling of erythrocytes. 
 
4.4.  Honokiol in the triggering of erythrocyte cell membrane 
scrambling 
The present study explored, whether honokiol triggers eryptosis, the 
suicidal death of erythrocytes. The results indicate that using honokiol to treat 
erythrocytes drawn from healthy volunteers is followed by breakdown of 
phosphatidylserine asymmetry of the cell membrane and erythrocyte shrinkage 
expressing hallmarks of eryptosis. The concentrations required to trigger 
eryptosis (5 µM)  are well in the range of those concentrations (10 µM) applied 
on tumor cells to trigger apoptosis 189 . Other obsevations showed that lower 
concentrations of honokiol (0.125-1 µM) have in contrast the ability to 
counteract apoptosis 194 
plasma honokiol concentration augmented up to 1 g/l (≈ 4 mM) following  
in vivo administration of 250 mg/kg252. Moreover, the therapeutic plasma 
concentration was closing to 10 mg/l (≈ 40 µM) 252, 253. therefore, the apoptotic  
applied concentrations are indeed well pertinent to in vivo one.   
The erythrocyte shrinkage following honokiol treatment is most likely the 
result of increased cytosolic Ca2+ activity, which activates Ca2+ sensitive K+  
channels 20, 228 leading to cell membrane hyperpolarization. The increased 
electrical driving force drives Cl- exit and thus leads to cellular loss of KCl with 
osmotically obliged water 206 . 
The absence of extracellular Ca2+ resulted in a  significant blunting  of 
phosphatidylserine asymmetry breakingdown of the erythrocyte cell membrane, 
this blunting at least in part due to increase of cytosolic Ca2+ activity ([Ca2+]i). 
Cell membrane scrambling with phosphatidylserine translocation from the inner 
leaflet of the cell membrane to the outer leaflet of the cell membrane is well 
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admitted of being stimulated by an increase of [Ca2+]i 203. Fundamental 
mechanisms of Ca2+ entry comprise Ca2+ permeable non selective cation 
channels comprising the transient receptor potential channel TRPC6 77 . 
Oxidative stress can activate the Ca2+ permeable erythrocyte cation channels 
as well 209 . 
All the same, high concentrations (15 µM) of honkiol were in demand to 
increase [Ca2+]i appreciably. However, in the current study to some extent 
astonishingly at lower honokiol concentrations, the presence of Ca2+ plays 
crucial role in the honokiol impact on phosphatidylserine translocation without 
necessary requirement for [Ca2+]i increase. 
Honokiol-induced phosphatidylserine translocation is blunted but not  
completely abolished in the nominal absence of extracellular Ca2+, indicating to 
involvement of additional mechanisms. Those mechanisms include formation of 
ceramide, Ceramide is well known having the ability to enhance Ca2+ sensitivity 
of phosphatidylserne translocation 210. In reality, honokiol treatment  could 
stimulate an increase of ceramide formation, where ceramide is known to 
trigger breakdown of cell membrane phosphatidylserine asymmetry in 
erythrocytes 210.  
Consequences of enhanced eryptosis include anemia. In vivo, eryptotic 
erythrocytes are followed by clearance of eryptotic erythrocytes from circulating 
blood where trapped in the spleen and thus rapidly removed 218. Anemia 
development aggravates gradually unless the loss of erythrocytes by triggering 
of eryptosis is not well compensated with a similar enhancement of 
erythropoiesis218.  
 Excessive enhanced eryptosis can further causes adhesion of 
phosphatidylserine exposing erythrocytes to endothelial CXCL16/SR PSO 238 . 
At least in theory, accordingly, microcirculation and interfere with blood flow 
could be  compromized by the adhesion of erythrocytes to the vascular wall 214, 
215, 238, 239, 254, 255. The effect may be compounded by the stimulating effect of 
phosphatidylserine exposure on blood clotting, which may bring up the 
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development of thrombosis214, 216, 217 . Based on the above, honokiol treatement 
may be accompanied with an augmented risk of thromboembolic events 
.
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5. SUMMARY 
 
Eryptosis, the suicidal death of erythrocytes, is characterized by 
erythrocyte shrinkage, membrane blebbing, cell membrane phospholipid  
scrambling with eventually phosphatidylserine exposure at the red cell surface. 
Increased cytosolic Ca2+ activity  triggers eryptosis, where this extra activity 
may explained by  Ca2+ entry through Ca2+ -permeable cation channels. 
Phosphatidylserine-exposing erythrocytes are rapidly cleared from circulating 
blood, where respective receptors of macrophages can recognize  the exposing 
death signal of eryptotic cells, which give further the order for engulfing and 
degrading. 
As a result, excessive eryptosis can play a crucial physiological role of  
determining erythrocyte fate, therefore, accelerated cases of eryptosis may 
participate in anemia  unless the considerd loss of erythrocytes is compensated 
by enough enhanced generation of new erythrocytes.  
In an industrialized society, residential, commercial and industrial sources 
discharge daily various forms of contaminants to the environment. However,   
accumulated significant discharge of a contaminant/hazardous substance has  
dual potential effect on human health and the surrounding environment. 
The first study explored, whether chromium (VI) as a environmental 
contaminants is capable to trigger eryptosis, a possible reason for anemia, and 
if so, whether the chromium (VI) induced eryptosis using a hall mark alterations 
of cytosolic Ca2+ activity, ceramide formation and/or cytosolic ATP levels. 
According to annexin-V-binding in FACS analysis, chromium (VI)  (10 µM) 
stimulated phosphatidylserine exposure, this effect significantly blunted in the 
nominal absence of Ca2+. According to Fluo3 fluorescence, chromium (VI)  
increased cytosolic Ca2+ activity and decreases cytosolic ATP concentration, 
both are considered to be presumably major contributers to the stimulation of 
eryptosis, Where ceramide abundance was not significantly modified. In 
conclusion, the present observations may shed additional light on the effects of
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chromium (VI) on enucleated cells, chromium (VI) stimulates Ca2+ entry and 
ATP depletion in erythrocytes, which in turn lead to cell membrane scrambling 
and cell shrinkage,  similarly in nucleated cells. 
The second study explored, whether the pesticide intoxication rotenone,  
a cause of Parkinson’s disease stimulates apoptosis and elucidate underlying 
mechanisms. Following exposure of human erythrocytes to rotenone, it was 
indeed able to scramble the cell membrane in addition to cell shrinkage at 
required concentration for this effect  1 µM.  Rotenone increases cytosolic Ca2+ 
activity due to activation of Ca2+ permeable cation channels, which further leads 
to  Ca2+ sensitive K+ channels activation followed by  many cellular events such 
KCl loss, exit of osmotically obliged water and thus cell shrinkage. The effect of 
rotenone is, however, not fully abrogated by removal of extracellular Ca2+, 
pointing to the participation of an additional mechanism related to stimulation of 
ceramide formation. Ceramide sensitizes erythrocytes to the scrambling effect 
of Ca2+ and thus stimulates cell membrane scrambling in erythrocytes. 
The third and fourth studies explored the involvement of two natural products 
in the regulation of eryptosis. They are chemical substance produced by a living 
organism that have distinctive pharmacological effects. By applying Apigenin 
and Honokiol, Fluo3 fluorescence was employed  to estimate cytosolic Ca2+ 
concentration, forward scatter to analyse cell volume and annexin V-binding to 
disclose phosphatidylserine exposure by Facs analysis, as a result Apigenin 
and Honokiol  share thier proeryptotic activity with a wide variety of xenobiotics 
similarly triggering eryptosis. Apigenin and Honokiol are partially effective by 
stimulating Ca2+ entry with subsequent activating nonselective cation channels, 
Cell membrane scrambling is stimulated by ceramide, which is similarly known 
to trigger apoptosis of nucleated cells. The effect of apigenin on  decreasing 
cytosolic ATP concentration could result from enhanced ATP utilization or 
impaired formation of ATP by interference with glycolytic flux. 
Taken together, the study displays the functional significance of some 
xenobiotics which directly or indirectly regulate the suicidal erythrocyte death 
and survival.  
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7. Zusammenfassung 
Eryptose, der suizidale Zelltod von Erythrozyten, ist durch 
Zellschrumpfung, Ausknospung der Zellmembran („Blebbing“) sowie durch die 
Exposition von Phosphatidylserin an der Zelloberfläche, als Folge der 
Umlagerung der Phospholipide der Zellmembran („Scrambling“), 
gekennzeichnet. 
Eine erhöhte intrazelluläre Ca2+- Aktivität löst Eryptose aus, wobei dieser 
zusätzliche Ca2+-Einstrom durch den erythrozytären Ca2+ durchlässigen 
Kationenkanal erklärt wird. Phosphatidylserin exponierende Erythrozyten 
werden schnell aus dem zirkulierenden Blut eliminiert, da Makrophagen das 
exponierte Phosphatidylserin als Todessignal der Erythrozyten erkennen und 
deren Abbau durch Phagozytose einleiten.  
Eine übermäßige Eryptose spielt eine entscheidende physiologische 
Rolle bezüglich des Schicksals von Erythrozyten. Deshalb trägt eine erhöhte 
Eryptose möglicherweise zu Anämie bei, wenn der Verlust von Erythrozyen 
nicht durch die Bildung neuer Erythrozyten ausgeglichen wird. 
In der industrialisierten Gesellschaft führen wohn-, gewerbliche und 
industrielle Quellen täglich zu einem Eintrag verschiedener Formen von 
Schadstoffen in die Umwelt. Jedoch hat eine Akkumulation von gefährlichen 
Substanzen eine potentiell schlimmere Wirkung auf die menschliche 
Gesundheit und deren Umgebung.  
In der ersten Studie wurde untersucht, ob Chrom (VI) als 
Umweltschadstoff Eryptose auslöst, welche ein möglicher Grund für Anämie ist, 
und wenn ja, ob Chrom (VI) Eryptose mit den für diesen Vorgang 
charakteristischen Veränderungen der cytosolischen Ca2+-Aktivität, der 
Ceramidbildung und/  oder des zytosolischen ATPs induziert. 
Der Annexin-V-Bindung im FACS zufolge, stimulierte Chrom (VI) (10 uM) 
die Phosphatidylserin-Exposition, wobei dieser Effekt bei Abwesenheit von Ca2+ 
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signifikant abgeschwächt war. Bei Betrachten der Fluo3 Fluoreszenz, erhöhte 
Chrom (VI) die intrazelluläre Ca2+-Aktivität und verminderte die cytosolische 
ATP Konzentration, wobei beide wichtige Faktoren für die Stimulation der 
Eryptose sind.  Die Ceramidbildung wurde jedoch durch das Vorhandensein 
von Chrom nicht beeinflusst. 
Schlussfolgernd lässt sich sagen, dass diese Beobachtungen zur 
Aufklärung der Auswirkung von Chrom (VI) auf Zellen ohne Zellkern beitragen, 
wobei Chrom (VI) den Ca2+-Einstrom und den ATP-Abbau in Erythrozyten 
stimuliert, was wiederum zur Umlagerung der Phospholipide der Zellmembran 
(”Scrambling”) und zum Zellschrumpfen, ähnlich wie bei kernhaltigen Zellen, 
führt.  
In der zweiten Studie wurde untersucht, ob das Pestizid Rotenon , ein 
Verursacher der Parkinson-Krankheit, Apoptose stimuliert, wobei die zugrunde 
liegenden Mechanismen aufgeklärt werden sollten. Nach Exposition 
menschlicher Erythrozyten mit 1 uM Rotenon, führte dies zur Umlagerung der 
Membran und zum Zellschrumpfen. Rotenon erhöhte ebenfalls die  
intrazelluläre Ca2+ - Konzentration durch Aktivierung Ca2+ durchlässiger 
Kationenkanäle, was wiederum zur Aktivierung Ca2+ sensitiver K+ Kanäle und 
zum Austritt von KCl  und Wasser und somit zum Zellschrumpfen beiträgt.  
Die Wirkung von Rotenon wird jedoch nicht vollständig durch das 
Entfernen von extrazellulärem Ca2+ aufgehoben, was auf die Beteiligung eines 
weiteren Mechanismus im Zusammenhang mit der Stimulation der Ceramid-
Bildung deutet. Ceramid sensibilisiert Erythrozyten in Bezug auf den 
Umlagerungseffekt von Ca2 + und stimuliert daher die Umlagerung der Membran 
in Erythrozyten. 
Die dritte und vierte Studie untersuchten die Beteiligung von zwei 
natürlichen Substanzen in der Regulation der Eryptose. Beide sind chemische 
Substanzen, die von einem lebenden Organismus erzeugt werden und eine 
gezielte pharmakologische Wirkung haben. Um die Wirkung von Apigenin und 
Honokiol zu untersuchen, wurde Fluo3 für die Bestimmung der intrazellulären 
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Ca2+ Konzentration eingesetzt, das Vorwärtsstreulicht für das Zellvolumen und 
die Annexin V-Bindung zum Nachweis von Phosphatidylserin. 
Apigenin und Honokiol sind Teil einer Vielzahl von Xenobiotika, die 
Eryptose auslösen. Apigenin und Honokiol sind teilweise wirksam durch die 
Stimulation des Ca2+  Einstroms mit anschließender Aktivierung nicht-selektiver 
Kationen-Kanäle. Weiterhin führen sie zur Umlagerung der Zellmembran durch 
Ceramidbildung, wobei bekannt ist, dass Ceramid zur Apoptose kernhaltiger 
Zellen beiträgt. Die Wirkung von Apigenin auf die Verminderung der 
zytosolischen ATP-Konzentration könnte durch eine verbesserte ATP Nutzung 
oder durch eine eingeschränkte Bildung von ATP durch Interferenz mit dem 
glykolytischen Fluss erklärt werden. Insgesamt zeigt die Studie die Bedeutung 
einiger Xenobiotika, die direkt oder indirekt den suizidalen Erythrozytentod oder 
deren Überleben regulieren. 
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